Refine
Has Fulltext
- yes (364)
Is part of the Bibliography
- yes (364)
Year of publication
- 2012 (364) (remove)
Document Type
- Journal article (364) (remove)
Language
- English (364) (remove)
Keywords
- Medizin (40)
- hadron-hadron scattering (15)
- Biologie (13)
- Psychologie (9)
- systematic uncertainty (9)
- cancer (8)
- gene expression (8)
- expression (7)
- jet energy scale (7)
- protein (7)
- brain (6)
- in vitro (6)
- Chemie (5)
- binding (5)
- differentiation (5)
- genome-wide association (5)
- melanoma (5)
- mice (5)
- therapy (5)
- transverse momentum (5)
- ATLAS (4)
- Atlas detector (4)
- apoptosis (4)
- cells (4)
- disease (4)
- gene (4)
- genetics (4)
- identification (4)
- inhibitor (4)
- jet energy resolution (4)
- messenger RNA (4)
- metaanalysis (4)
- model (4)
- neuroprotection (4)
- receptor (4)
- resistance (4)
- signal transduction (4)
- single-crystal X-ray study (4)
- survival (4)
- tumors (4)
- validation (4)
- MC simulation (3)
- MRI (3)
- SM background (3)
- T cells (3)
- association (3)
- breast-tumors (3)
- central-nervous-system (3)
- children (3)
- classification (3)
- colony-stimulating factor (3)
- emotion (3)
- epithelial cells (3)
- escherichia coli (3)
- genes (3)
- jet energy scale uncertainty (3)
- light quark jet (3)
- lung (3)
- lung cancer (3)
- magnetic resonance imaging (3)
- multijet background (3)
- multiple sclerosis (3)
- non-prompt lepton (3)
- progression (3)
- quality of life (3)
- serum (3)
- stroke (3)
- top quark mass (3)
- top quark pair (3)
- trial (3)
- ubiquitin (3)
- 5-HT1A (2)
- 5-HT2C (2)
- ADHD (2)
- Alzheimers disease (2)
- Anti-k Jet (2)
- BDNF (2)
- Cl Lowe limit (2)
- EF-1A (2)
- FAAH (2)
- HIV (2)
- Image-guidance (2)
- JES uncertainty (2)
- MC event generator (2)
- NPY (2)
- Pp Collision (2)
- RNA-seq (2)
- Radiosurgery (2)
- Raf kinases (2)
- T = 100 K (2)
- T cell (2)
- West Africa (2)
- ablation (2)
- acceptance time efficiency (2)
- acute kidney injury (2)
- adalimumab (2)
- african trypanosomes (2)
- angiogenesis (2)
- anti-k jet (2)
- antirheumatic agents (2)
- architecture (2)
- astrocytes (2)
- basal ganglia (2)
- biomarkers (2)
- blood pressure (2)
- blood-brain barrier (2)
- breast cancer (2)
- calorimeter (2)
- cancer cells (2)
- carcinoma (2)
- cerebral ischemia (2)
- chemotherapy (2)
- ciliary neurotrophic factor (2)
- climate change (2)
- closed head injury (2)
- coagulation (2)
- combination therapy (2)
- comparative genomic hybridization (2)
- decision making (2)
- deficient mice (2)
- degeneration (2)
- dependent protein-kinase (2)
- depression (2)
- disease progression (2)
- diversity (2)
- domain (2)
- down regulation (2)
- endocannabinoid (2)
- endophenotype (2)
- endothelial cells (2)
- enterica serovar typhimurium (2)
- environment (2)
- fake lepton (2)
- films (2)
- focal cerebral-ischemia (2)
- follow up (2)
- functional characterization (2)
- giant ventral hernia (2)
- ideomotor theory (2)
- immunoreactive neurons (2)
- in vivo (2)
- in-vitro (2)
- inflammation (2)
- injury (2)
- jet channel (2)
- jet reconstruction efficiency (2)
- jet transverse momentum (2)
- kinase (2)
- laparostomy (2)
- lines (2)
- linkage (2)
- living cells (2)
- localization (2)
- magnetic resonance (2)
- malaria (2)
- mass spectrometry (2)
- mechanisms (2)
- melanogaster (2)
- metastasis (2)
- microenvironment (2)
- microglia (2)
- migration (2)
- multi-jet background (2)
- muon channel (2)
- mutation (2)
- mutations (2)
- myocardial infarction (2)
- myocardial-infarction (2)
- neurons (2)
- nude-mice (2)
- olfactory memory (2)
- oncolysis (2)
- open abdomen (2)
- ovarian cancer (2)
- oxidative stress (2)
- partial decay width (2)
- pathway (2)
- peptide vaccination (2)
- perception (2)
- perspectives (2)
- phosphorylation (2)
- prevalence (2)
- primary vertex (2)
- randomized controlled trial (2)
- recognition (2)
- regression analysis (2)
- resolution (2)
- responses (2)
- rheumatoid arthritis (2)
- sample (2)
- schizophrenia (2)
- signal cross section (2)
- simulated signal event (2)
- single top event (2)
- single top production (2)
- single top quark (2)
- single top quark production (2)
- sleep (2)
- sleep disorders (2)
- smooth muscle cells (2)
- speech perception (2)
- staphylococcus aureus (2)
- startle reflex (2)
- stem cells (2)
- surface (2)
- susceptibility gene (2)
- synthetic mesh (2)
- tissue (2)
- tolerance (2)
- top quark decay (2)
- trabeculectomy (2)
- transcription (2)
- transmission (2)
- traumatic brain injury (2)
- treatment outcome (2)
- triple in situ hybridization (2)
- tumor (2)
- vacuum conditioning (2)
- variability (2)
- variants (2)
- virulence (2)
- visible cross section (2)
- wR factor = 0.068 (2)
- 1/N expansion (1)
- 14.7K (1)
- 1p13.3 (1)
- 1q21 (1)
- 2',7'-dichlorofluorescin (1)
- 2,5-diketopiperazines (1)
- 5-HT transporter (1)
- 68Ga-DOTATATE (1)
- 7000 GeV-cms (1)
- 7q11.2 (1)
- A-type lamins (1)
- ACC deaminase (1)
- AGT (1)
- ALK-1 (1)
- ALMT (1)
- ALS (1)
- AMD (1)
- ARF (1)
- ATLAS detector (1)
- Advanced snowmelt (1)
- Ag(111) (1)
- Alps (1)
- Alzheimer's disease (1)
- Alzheimer’s disease (1)
- Amazonia (1)
- Animal models (1)
- Arabidopsis (1)
- Araneae (1)
- Aspergillus fumigatus (1)
- Aspergillus niger (1)
- Atherosclerotic plaque (1)
- Attentional performance (1)
- AuxRE (1)
- Auxin-regulated transcription (1)
- B cell (1)
- B cells (1)
- B neisseria meningitidis (1)
- B-tagged jet (1)
- BBCH (1)
- BK virus (1)
- BRCA1 (1)
- BRCA1 positive (1)
- BRCA1/2 negative (1)
- BRCA2 positive (1)
- Bacillus megaterium (1)
- Biochemie (1)
- Blut-Hirn-Schranke (1)
- Botanik (1)
- Bowen’s disease, periungual (1)
- Brain edema (1)
- Brain ischemia (1)
- Brugia Malayi (1)
- Bullous pemphigoid (1)
- C-13 NMR (1)
- C-MYC (1)
- C-reactive protein (1)
- C57BL/KALWRIJ mouse (1)
- C9orf72 (1)
- CCL2 (MCP-1) (1)
- CD30 (1)
- CD4(+) (1)
- CD4(+) T-cells (1)
- CD95 (1)
- CENP-A (1)
- CERN LHC Coll (1)
- CIS+ (1)
- CMR (1)
- COMT VAL(158)MET polymorphism (1)
- COPD diagnosis (1)
- CSE4, CENP-A (1)
- CSF (1)
- CXCL8 (IL-8) (1)
- Caco-2 (1)
- Camponotus floridanus (1)
- Cardiovascular risk factors (1)
- Cerebral blood flow (1)
- Cerebral vasospasm (1)
- Charcot–Marie–Tooth disease (1)
- Cis-elements (1)
- Cisterna magna (1)
- Climate change (1)
- Coexpression (1)
- Cognitive (1)
- Colloids (1)
- Combination (1)
- Commercial preparations (1)
- Cone-beam CT (1)
- Contaminants (1)
- Coronary artery bypass graft (1)
- Cryolesion (1)
- Crystalloids (1)
- Cushings syndrome (1)
- Cystic fibrosis (1)
- DNA Methylation (1)
- DNA repair (1)
- DNA repeat expansion (1)
- DNA replication (1)
- DNA-binding vesicles (1)
- DOT1 (1)
- DRD2 (1)
- Danish hernia database (1)
- Delayed snowmelt (1)
- Depression (1)
- Diabetes (1)
- Dickblattgewächse (1)
- Double hemorrhage model (1)
- E3 14.7-kilodalton protein (1)
- E3 ubiquitin ligase (1)
- EBRT (1)
- ECG-recording (1)
- ECORN-CF Projekt (1)
- EHS classification (1)
- EMG (1)
- EORTC-BN20 (1)
- EORTC-QLQ-C15-PAL (1)
- EP Procedures (1)
- ERP-BCI (1)
- ERPS (1)
- ETR (1)
- Emery-Dreifuss muscular dystrophy (1)
- European beech (1)
- European countries (1)
- European experience (1)
- Experimental brain trauma (1)
- Extended field irradiation (1)
- FAS (1)
- FMRI (1)
- FXII (1)
- Fabry disease (1)
- Fanconi-anemia subtype (1)
- Flowering (1)
- Foamy virus (1)
- Follicular lymphoma (1)
- Fontan’s Operation (1)
- Frabin/Fgd4 (1)
- Frame-based (1)
- Frame-less (1)
- Functional modules (1)
- GABA(A) receptors (1)
- GMSB model (1)
- GO1 (1)
- GOLD (1)
- GRN (1)
- GagPol fusion protein (1)
- Garcinia biflavonoids (1)
- Glucosetransportproteine (1)
- GlyRs (1)
- Glycosyltransferase (1)
- Göttingen (1)
- HBO (1)
- HES (1)
- HIV-1; subtype C; proviral plasmid; viral replication; resistance assays; Vpu; CD317; CD4 (1)
- HLA (1)
- HPLC-MS/MS method (1)
- HRAS (1)
- HaCaT cells (1)
- Hadron-Hadron Scattering (1)
- Helicobacterpylori (1)
- Hepatitis C infection (1)
- Higgs (1)
- Higgs boson signal (1)
- Holliday junction reolvass (1)
- Hospitalization (1)
- Human papillomavirus (1)
- II type-2 receptor (1)
- IL-12 production (1)
- IL-17 (1)
- IL28B (1)
- IMpACT (1)
- IVF-methods (1)
- Imd pathway (1)
- Immunoadsorption (1)
- Immunoapheresis (1)
- Infectious disease (1)
- Inferior vena cava (1)
- Influenza (1)
- Integrase (1)
- Integrated network analysis (1)
- Inter-observer variability (1)
- JES (1)
- Japanese population (1)
- KATP channel (1)
- L cells (1)
- LHC (1)
- LMNA mutations (1)
- LPHN3 (1)
- LTD (1)
- Lamto Reserve (1)
- Large Hadron Collider (1)
- Lung cancer (1)
- MC expectation (1)
- MC program (1)
- MCPH1 (1)
- MK801 (1)
- MODIS (1)
- MR guidance (1)
- MRSA (1)
- MS (1)
- MYB (1)
- MYC (1)
- Macrophage (1)
- Magnetfeld (1)
- Martensit (1)
- Mehrskalenmodell (1)
- Melatonin (1)
- Meningioma (1)
- Mesh Augmentation (1)
- Metabolic pathways (1)
- Metabolic profiles (1)
- Mice (1)
- Microcirculation (1)
- Micromonospora (1)
- Milnesium tardigradum (1)
- Minischwein (1)
- Monte Carlo (1)
- Monte Carlo methods (1)
- Motor cortex (1)
- Motor plasticity (1)
- Multiple sclerosis (1)
- Mycobacterium caprae (1)
- Mycobacterium tuberculosis complex (1)
- Mycoplasma (1)
- N-Myc down regulated gene 1 (1)
- N170 (1)
- NA/I symporter (1)
- NADPH oxidase (1)
- NADPH oxidases (NOX) (1)
- NCAM1 (1)
- NDVI (1)
- NF-kappa-B (1)
- NI(111) (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMDAR (1)
- NMO-IGG (1)
- NP-hardness (1)
- NRPS (1)
- Nail unit (1)
- New Zealand (1)
- New mexico (1)
- Nothotaxa (1)
- OPUS (1)
- Oligofructoside (1)
- O–I 1 fluorescence rise (1)
- P15(INK4B) (1)
- P21 (1)
- P300 (1)
- P300-Speller (1)
- P67(PHOX) (1)
- PAR (1)
- PARM (1)
- PBPK/PBTK model (1)
- PDF set (1)
- PIK3CA mutations (1)
- POZ domain (1)
- PPAR-gamme (1)
- PRRT (1)
- Pain (1)
- Parkinsons disease (1)
- Parkinson’s disease (1)
- Pediatric (1)
- Peptide receptor radionuclide therapy (1)
- Phase II trial (1)
- Phasenumwandlung (1)
- Physiologie (1)
- Porifera (1)
- Prednisolon (1)
- Prostatakrebs (1)
- Psychiatrie (1)
- QCD (1)
- QCD background (1)
- QUAC (1)
- R factor = 0.018 (1)
- R factor = 0.025 (1)
- R factor = 0.027 (1)
- R-715 (1)
- RAD51C (1)
- RNA (1)
- RNA denaturation (1)
- RNA sequencing (1)
- RNA structure (1)
- RNA synthesis (1)
- RNA-polymerase-II (1)
- Radiotherapy (1)
- Rat (1)
- Regulation of protease activity (1)
- Renal cell carcinoma (1)
- Respiration correlated imaging (1)
- Rho-GTPase Cdc42 (1)
- SCF (1)
- SER/THR kinase (1)
- SGLT1 (1)
- SIRP-alpha (1)
- SKP1 (1)
- SLAC/SLAH (1)
- SLX4 (1)
- SM Background (1)
- SM proteins (1)
- SOD1 mutations (1)
- SST (1)
- ST1797 (1)
- ST88 (1)
- STAIR (1)
- SUSY breaking scale (1)
- SVR (1)
- SacB (1)
- Sahel (1)
- Salmonella enterica (1)
- Salmonella-containing vacuole (1)
- Savanna (1)
- Savannas (1)
- Schlaganfall (1)
- Schwann cells (1)
- Scleroderma (1)
- Secondary traumatic brain damage (1)
- Sedum rupestre L. subsp. erectum ‘t Hart (1)
- Sepsis (1)
- Serengeti (1)
- Short dsRNA oligonucleotides (1)
- Somatostatin receptor (1)
- South Africa (1)
- Spectrofluorimetry (1)
- Spinal metastasis (1)
- Stereotactic (1)
- Stereotactic body radiotherapy (1)
- Stim (1)
- Strahlentherapie (1)
- Subarachnoid (1)
- Subarachnoid hemorrhage (1)
- Suc1 (1)
- Synthesis (1)
- T = 173 K (1)
- T = 199 K (1)
- T cell development (1)
- T helper cell (1)
- T(H)17 cells (1)
- T-PA (1)
- T-antigen (1)
- T-cell reactivity (1)
- T1 (1)
- T3s (1)
- TGF-BETA (1)
- TIC disorder (1)
- TMS (1)
- TNF-alpha (1)
- TNF-α (1)
- TO-target interval (1)
- TOJ (1)
- Tanzania (1)
- Thrombectomy (1)
- Total nodal irradiation (1)
- Toxikologie (1)
- Trend test (1)
- Trigger System (1)
- Tuberkulose (1)
- Tumor thrombus (1)
- United States (1)
- Univted-States (1)
- Uzbekistan (1)
- VAL66MET polymorphism (1)
- Variationsrechnung (1)
- Variovorax paradoxus (1)
- WNT signaling pathway (1)
- WW (1)
- WZ production (1)
- West-Africa (1)
- XA (1)
- Yolk protein (1)
- abdominal (1)
- abdominal wall hernia (1)
- abdominal wall surgery (1)
- abiotic formation (1)
- abscisic acid (1)
- absolute configuration (1)
- accelerated atherosclerosis (1)
- acetivorans C2A (1)
- acoustic communication (1)
- acoustic startle (1)
- actin cortex (1)
- actin cytoskeleton (1)
- actinomycetes (1)
- action planning (1)
- action-effects (1)
- activated-receptor gamma (1)
- activation (1)
- activation mechanism (1)
- acute ischemic stroke (1)
- acute myeloid leukemia (1)
- acute renal failure (1)
- adaption (1)
- addiction (1)
- addicts (1)
- additional jet (1)
- adenovirus (1)
- adhesion (1)
- adipose tissue (1)
- adjuvant hormonal treatment (1)
- adolescence (1)
- adsorption (1)
- adult bee (1)
- adult drosophila (1)
- age (1)
- age-related osteoporosis (1)
- agency (1)
- aging (1)
- aging brain (1)
- agnoists (1)
- agonist (1)
- airway (1)
- akt (1)
- alagille syndrome (1)
- alias pilot trial (1)
- alignment (1)
- alkaline-phosphatase (1)
- alleles (1)
- alpha galactosidase (1)
- alpha-synuclein (1)
- alveoar echinococcosis (1)
- alveolar epithelium in vitro model, claudin-1, claudin-3, claudin-4, claudin-5 (1)
- aminoacyl-transfer-RNA (1)
- amplitude (1)
- amygdala (1)
- amyotrophic lateral sclerosis (1)
- anal atresia (1)
- anaplastic large cell lymphoma (1)
- anesthetics (1)
- aneurysm repair (1)
- angiography (1)
- angioplasty (1)
- angiotensin II (1)
- animal communication (1)
- animal ecology (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- anion channel (1)
- annihilation (1)
- anomaly mediation (1)
- anorectal malformation (1)
- ant communities (1)
- anterior insula (1)
- anthropogenic noise (1)
- anti inflammation (1)
- anti-aquaporin-4 antibody (1)
- anti-proliferative effects (1)
- anti-protease (1)
- anti-tumor agents (1)
- antibacterial activity (1)
- antibiotic resistance (1)
- antibodies (1)
- antibody (1)
- anticipation (1)
- anticipatory mechanisms (1)
- antidepressant (1)
- antigen (1)
- antigen expression (1)
- antigen presentation (1)
- antigen-B (1)
- antimicrobial (1)
- antimicrobial activity (1)
- antioxidant (1)
- antisense RNA (1)
- antisense RNAs (1)
- anxiety like (1)
- aortic-valve (1)
- apolipoprotein E (1)
- appliances (1)
- approximation algorithm (1)
- aquaporin 3 protein (1)
- aquaporin-4 autoantibodies (1)
- aquired resistance (1)
- arabidopsi (1)
- arabidopsis (1)
- arabidopsis thaliana (1)
- arabidpsis thaliana (1)
- aral sea basin (1)
- archwires (1)
- area (1)
- arm (1)
- artery occlusion (1)
- arthritis (1)
- aryl hydrocarbon receptor (AhR) (1)
- asbestos (1)
- asparaginase (1)
- asparagine (1)
- asparagine synthetase (1)
- aspergillosis (1)
- assessment (1)
- assisitvetechnology (1)
- assisted reproductive techniques (1)
- associative learning (1)
- astrocyte (1)
- astrocytic tumor (1)
- astroglia (1)
- astrogliosis (1)
- atherothrombosis (1)
- atomic-force microscopy (1)
- atrial fibrillation (1)
- atrial natriuretic peptide (1)
- attention (1)
- auditory discrimination (1)
- auditory masking (1)
- aureus infections (1)
- auto-calibration (1)
- autologous chondrocyte implantation (1)
- autophagy (1)
- avaliação de risco (1)
- axial skeletal defects (1)
- axonal degeneration (1)
- axonopathic changes (1)
- bZIP (1)
- bacillus calmette guerin (1)
- back pain (1)
- background (1)
- background cross section (1)
- background expectation (1)
- bacterial meningitis (1)
- bacterial persistence (1)
- bacterial signal molecule (1)
- bactericidal activity (1)
- balance (1)
- balloon distension (1)
- baroreflex mechanism (1)
- basal cell (1)
- beaver-dam eye (1)
- bee larva (1)
- behavior (1)
- behavioral addiction (1)
- benzo[a]pyrene (1)
- biflavanoids (1)
- big brown bats (1)
- bilayers (1)
- binary tanglegram (1)
- biocompatibility (1)
- bioengineering (1)
- biogenic amines (1)
- bipolar disorder (1)
- birth defects (1)
- bitter taste (1)
- blastocysts (1)
- bleomicina (1)
- bleomycin (1)
- blood biomarker (1)
- blood brain barrier (1)
- blood sampling (1)
- blood-brain-barrier (1)
- blood-stream forms (1)
- blowfly calliphora-vomitoria (1)
- bone disease (1)
- bone marrow (1)
- bone-mineral density (1)
- brain barrier (1)
- brain cancer (1)
- brain development (1)
- brain edema (1)
- brain tumours (1)
- brain-computer-interface (1)
- brain–computerinterface (1)
- brucei (1)
- burned savanna (1)
- c-myc (1)
- cEND (1)
- caenorhabditis elegans (1)
- caffeine-induced anxiety (1)
- call (1)
- calorimeter response (1)
- camp signaling pathway (1)
- cancer patients (1)
- cancer-cells (1)
- candidate gene (1)
- canine cancer therapy (1)
- canopy fogging (1)
- capsid protein (1)
- cardiac aging (1)
- cardiac arrhythmia (1)
- cardiac fibrosis (1)
- cardiac hyperthrophy (1)
- cardiac protection (1)
- cardiovascular arousal (1)
- cardiovascular disease (1)
- cardiovascular events (1)
- cardiovascular magnetic resonance (1)
- cardiovascular risk factors (1)
- care (1)
- carotid artery (1)
- case-control study (1)
- cased-control studies (1)
- catalytic (1)
- catenin (1)
- catheter tip (1)
- causal belief (1)
- causality (1)
- caveolin-1 (1)
- cavity (1)
- cavity polaritons (1)
- cell carcinoma (1)
- cell death (1)
- cell surface (1)
- cell-cycle arrest (1)
- cell-cycle regulation (1)
- cell-line (1)
- cell-penetrating peptides (1)
- centomeres (1)
- central corneal thickness (1)
- central nervous system (1)
- centromere (1)
- cephalic-vagal influences (1)
- cerebrospina (1)
- cerebrospinal fluid (1)
- cerebrospinal fluid culture (1)
- cerebrospinal-fluid (1)
- chain (1)
- chalinolobus-tuberculatus (1)
- charge misidentification (1)
- chargino --> neutralino pi (1)
- chargino decay (1)
- chargino lifetime (1)
- chargino mass (1)
- charingo mass (1)
- chemistry (1)
- chemosensory protein (1)
- chemosensory system (1)
- childhood cancer (1)
- children born (1)
- chiral boson (1)
- chlorella (1)
- chlorophyll fluorescence (1)
- cholinergic neurons (1)
- choroid-plexus (1)
- chromatin (1)
- chronic kidney disease (1)
- cigarette smoking (1)
- ciliary neurotrophic factor (CNTF) (1)
- ciliolenticular block glaucoma (1)
- circadian photoreception (1)
- circular dichroism (1)
- cis-element modules (1)
- clara cell (1)
- classifiaction (1)
- clinical diagnosis (1)
- clinical practice (1)
- clinical trial (1)
- clinical trials (1)
- clock (1)
- cluster (1)
- coa reductase inhibitors (1)
- cochlear implant (1)
- coding strategy (1)
- coexpression (1)
- coloteral cancer (1)
- commercial preparations (1)
- communication (1)
- community sample (1)
- compartmentalization (1)
- complement factor-H (1)
- complex stability (1)
- computational model (1)
- conditional promoter replacement (1)
- confinement (1)
- congenital malformations (1)
- conjugate (1)
- connector (1)
- conservation (1)
- consolidation (1)
- consortium (1)
- contact force (1)
- containing GABA(A) receptors (1)
- containing neurons (1)
- contaminants (1)
- contingent negative-variation (1)
- continuous performance-test (1)
- contralateral breast cancer (1)
- contrast (1)
- contrast-enhanced MRI (1)
- contrast-enhanced ultrasound. (1)
- conversion (1)
- cooperative-oncology-group (1)
- coordination (1)
- copy number variants (1)
- core depression (1)
- coronary artery bypass (1)
- coronary disease (1)
- coronary-heart-disease (1)
- coronene (1)
- cortex (1)
- corticotropin-releasing hormone (1)
- coupling strength (1)
- courtship displays (1)
- crantiectomy (1)
- criteria (1)
- critically ill (1)
- cropland abandonment (1)
- cross section measurement (1)
- cross section time (1)
- cross-sectional studies (1)
- crossing minimization (1)
- crosstalk (1)
- crystal structure (1)
- cubic-monoclinic martensites (1)
- cultivation (1)
- cultured hippocampal-neurons (1)
- cyanelle (1)
- cystic fibrosis (1)
- cytokine (1)
- cytokines (1)
- damage (1)
- damage cool aid (1)
- dart-poison frog (1)
- data-to-parameter ratio = 14.0. (1)
- data-to-parameter ratio = 14.6 (1)
- data-to-parameter ratio = 20.8 (1)
- data-to-parameter ratio = 22.3 (1)
- database (1)
- dead region (1)
- death (1)
- decay (1)
- decompressive surgery (1)
- deep sequencing (1)
- deep-vein thrombosis (1)
- deficit hyperactivity disorder (1)
- deficit-hyperactivity disorder (1)
- dehydrogenases (1)
- delays progression (1)
- dementia (1)
- demyelination (1)
- dendritic cells (1)
- dental casting alloys (1)
- dentate gyrus (1)
- dependent magnetosensitvity (1)
- depth (1)
- derivates (1)
- derivation (1)
- dermatite flagelada (1)
- dermatitis (1)
- descriptive epidemiology (1)
- deseases (1)
- detector track (1)
- detoxified lipooligosaccharide (1)
- developmental dyslexia (1)
- diabetes (1)
- diagnostic (1)
- diazepinomicin (1)
- differential diagnosis (1)
- diffractive dissociation (1)
- diketopiperazines (1)
- dilepton channel (1)
- dilepton invariant mass (1)
- dilepton invariant mass, (1)
- dilepton mass (1)
- diphoton invariant mass (1)
- direct pair production (1)
- discrete (1)
- disease-modifying therapies (1)
- disorder (1)
- disrupting chemicals (1)
- disruptor endócrino (1)
- dissociation process, (1)
- dogs (1)
- dopamine (1)
- dosage (1)
- double knockout mice (1)
- double-blind (1)
- doublecortine-like (1)
- drosophila embryo (1)
- drosophila melanogaster (1)
- drosophila mushroom body (1)
- drug (1)
- drug addiction (1)
- drug delivery (1)
- drug development (1)
- drug research and development (1)
- drug therapies (1)
- drug therapy (1)
- duchenne muscular dystrophy (1)
- dwelling bat (1)
- dyes (1)
- dynamics (1)
- dysfunction (1)
- dyspeptic symptoms (1)
- early diagnosis (1)
- eating disorders (1)
- ecosystem (1)
- electromagnetic calorimeter (1)
- electron energy deposition (1)
- electron probe microanalysis (1)
- electronic states (1)
- electroweak background (1)
- elementary mode analysis (1)
- elements (1)
- elongation (1)
- embolic stroke (1)
- emission-computed-tomography (1)
- emotional experience (1)
- encephalitis (1)
- endocrine disruptor (1)
- endogenous psychoses (1)
- endogenous shifts of attention (1)
- endothelial cell interactions (1)
- endothelial growth-factor (1)
- endotheliopathy (1)
- energy (1)
- energy conservation (1)
- energy dissipation (1)
- energy expenditure (1)
- energy scale (1)
- energy scale uncertainty (1)
- engineered measles-virus (1)
- engineering (1)
- enoxaparin (1)
- environmental phenols (1)
- environmental regulation (1)
- enzyme (1)
- enzyme replacement therapy (1)
- epicutaneous (1)
- epidemic (1)
- epidemiology (1)
- epigastric hernia (1)
- epimutation (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- eptesicus-fuscus (1)
- escherichia coli K-12 (1)
- estrogen receptor (1)
- estrogens (1)
- eucera berlandi (1)
- eukaryotes (1)
- event rates (1)
- event selcetion cut (1)
- event shape observable (1)
- event shape variable (1)
- event-related potentials (1)
- event-relatedpotentials (1)
- evolution (1)
- exchange factor collybistin (1)
- excitons (1)
- exercise (1)
- experimental (1)
- experimental autoimmune encephalomyelitis (1)
- experimental results (1)
- experimental stroke (1)
- experimental systematic uncertainty (1)
- exposição humana (1)
- expressed sequence tag (1)
- expression pattern (1)
- expression signature (1)
- extensiv transverse myelitis (1)
- extracellular matrix (1)
- extractives (1)
- extrapolation factor (1)
- eyes (1)
- fMRI (1)
- factor 1-alpha (1)
- factor EEF1A2 (1)
- factor H (1)
- factor prevents (1)
- failure (1)
- families (1)
- family (1)
- fear-potentiated startle (1)
- features (1)
- feeding behavior (1)
- femoral hernia (1)
- fetal liver (1)
- fibrosis progression (1)
- fiducial cross section (1)
- field gel-electrophoreresis (1)
- fine structure processing (1)
- fission yeast (1)
- fixed-parameter tractability (1)
- flagellar (1)
- flagellate dermatitis (1)
- flagellum (1)
- flavenoids (1)
- flavour changing (1)
- fluid (1)
- fluorescence detection (1)
- fluorescent protein (1)
- fluoride (1)
- follow-up (1)
- forced-choice (1)
- forest (1)
- forest disturbance (1)
- forest soils (1)
- formaldehyde (1)
- fosfomycin (1)
- fracture (1)
- fragmin (1)
- free radical scavenger (1)
- free-choice (1)
- frontotemporal dementia (1)
- frontotemporal lobar degeneration (1)
- fruit fly (1)
- functional absorption cross section of PS II (1)
- functional imaging (1)
- functional neuroanatomy (1)
- fungos shiitake (1)
- gadofluorine (1)
- gadolinium-DTPA (1)
- gait (1)
- galvanic corrosion (1)
- gamma (1)
- gamma-aminobutyric-acid (1)
- gamma-interferon (1)
- gene conversion (1)
- gene delivery (1)
- gene family targeting (1)
- geneexpression (1)
- general stress response (1)
- generalized anxiety disorder (1)
- genetic interaction (1)
- genetic loci (1)
- genetic modifiers (1)
- genetic renal disease (1)
- genetics of disease (1)
- genome-wide scan (1)
- genotyping (1)
- geometrically linear elasticity (1)
- geometrisch lineare Elastizitätstheorie (1)
- gephyrin (1)
- glaucoma surgery (1)
- glia (1)
- glioblastoma cell-lines (1)
- glioblastoma multiforme (1)
- glomerulonephritis (1)
- glucagon-like peptide-1 (GLP-1) (1)
- glucokinase (1)
- glut1 (1)
- glv-1h68 (1)
- glycine (1)
- glycoprotein Ib (1)
- go/no-go task (1)
- goldmann applanation tonometer (1)
- good agreement (1)
- gradient (1)
- grading system (1)
- graft surgery (1)
- granulosus (1)
- granzyme B (1)
- gravidez (1)
- growing escherichia coli (1)
- growth (1)
- growth factor (1)
- growth rate control (1)
- growth regulator (1)
- growth-factor receptor (1)
- guttiferae (1)
- hadron hadron scattering (1)
- hadronic final state (1)
- hadronisation model (1)
- haemolymph (1)
- hardwood dust (1)
- harmonia axyridis (1)
- harmonine (1)
- head involution (1)
- health-related quality of life (1)
- hearing loss (1)
- heart (1)
- heart-rate-variability (1)
- heartbeat perception (1)
- heat shock protein Hsc-70 (1)
- heavy flavour (1)
- heavy flavour quark (1)
- heavy neutrino (1)
- helicase BRIP1 (1)
- helicity fraction (1)
- helper T cells (1)
- hemagglutinin (1)
- hemicraniectomy (1)
- hemodialysis (1)
- hemophilus influenzae (1)
- hereditary motor and sensory neuropathy (1)
- heritability (1)
- hernia defect (1)
- hernia repair material (1)
- hexanucleotide repeat (1)
- hierarchy (1)
- high jet multiplicity (1)
- high-dose atorvastatin (1)
- high-resolution analysis (1)
- high-temperature NMR (1)
- higher pitch (1)
- highland malaria (1)
- highlands (1)
- hindbrain boundary (1)
- hippocampal neurogenesis (1)
- histidine kinase (1)
- homeostasis (1)
- homology modeling (1)
- honey bee (1)
- honey bees (1)
- honeybees (1)
- hormone flow modelling (1)
- hormone-related protein (1)
- host cell death (1)
- host genetics (1)
- human (1)
- human cancer diseases (1)
- human diseases (1)
- human endothelial cells (1)
- human exposure (1)
- human genetics (1)
- human jagged1 (1)
- human keratinocytes (1)
- human monocytes (1)
- human pathogens (1)
- humans (1)
- hydatid disease (1)
- hydrodynamics (1)
- hymenoptera (1)
- hyper-IL-6 (1)
- hyperekplexia (1)
- hypertension (1)
- idiotype (1)
- immortalization (1)
- immune response (1)
- immune suppression (1)
- immune-response (1)
- immunity (1)
- immunization (1)
- immunoglobulin-G (1)
- immunohistochemistry (1)
- immunology (1)
- immunosenescence (1)
- immunostaining (1)
- imperforate anus (1)
- in situ guided tissue regeneration (1)
- in vitro cell culture models (1)
- in vivo imaging (1)
- in-vitro fertilization (1)
- in-vitro propagation (1)
- in-vivo (1)
- inactivation (1)
- incisional abdominal wall hernia (1)
- incisional hernia (1)
- inclusive jet sample (1)
- individual systematic uncertainty (1)
- induction (1)
- infants born (1)
- infected bee (1)
- infection (1)
- infiltrate (1)
- inflammatory cytokines (1)
- inflammatory mechanisms (1)
- influenza (1)
- information (1)
- ingle-molecule microscopy (1)
- inguinal hernia (1)
- inhibitory synapse (1)
- inos (1)
- insect immunity (1)
- insecticides (1)
- instrument (1)
- integration (1)
- intensity-modulated radiotherapy (1)
- intent (1)
- intentional binding (1)
- interferon gamma (1)
- interferon-gamma (1)
- interleukin 6 (1)
- interleukin-1 receptor antagonist (1)
- interleukin-6-type cytokines (1)
- internal fixation (1)
- internal transcribed spacer 2 (1)
- internalization studies (1)
- intervention (1)
- intraarticular fractures (1)
- intracellular pathogen (1)
- intractable hiccup (1)
- intramolecular Michael addition (1)
- intravenous glucose tolerance test (1)
- invadopodia (1)
- invariant mass (1)
- invariant mass distribution (1)
- invariant mass resolution (1)
- investigators (1)
- iodine contrast (1)
- iron oxide nanoparticles (1)
- ischaemic stroke (1)
- ischemia (1)
- ischemia-reperfusion injury (1)
- ischemic cascade (1)
- ischemic stroke (1)
- isolation requirement (1)
- isthmic oragnizer (1)
- italian population (1)
- jet axis (1)
- jet background (1)
- jet calibration (1)
- jet cross section (1)
- jet energy (1)
- jet energy measurement (1)
- jet multiplicity (1)
- jet response (1)
- jet sample (1)
- jet scale energy (1)
- judgements (1)
- kidney (1)
- kingdom (1)
- kinin receptors (1)
- knock-out mice (1)
- knockout mice (1)
- kubisch-monokliner Phasenübergang (1)
- label-free analysis (1)
- lacking (1)
- laminopathies (1)
- land (1)
- land use (1)
- large rapidity gap (1)
- larva (1)
- laser suture lysis (1)
- learning performances (1)
- legionella pneumophila (1)
- lepton flavour (1)
- leptonic final state (1)
- lesion formation (1)
- lesion size (1)
- leukemia-inhibitory factor (1)
- leukocyte adhesion (1)
- life events (1)
- life style (1)
- life-span regulation (1)
- light avoidance (1)
- lineage (1)
- linear trend analysis (1)
- lipid-lowering therapy (1)
- livingstonei (1)
- locomotor activity (1)
- locus coeruleus (1)
- logistic regression modeling (1)
- long-term reuse (1)
- long-term-memory (1)
- low molecular weight (1)
- lower limit of normal (1)
- lower reaches of Amu Darya River (1)
- macrophages (1)
- macular degeneration (1)
- maculopathy (1)
- magnetic resonsance imaging (1)
- magnetic-resonance-spectroscopy (1)
- major depression (1)
- malaria model (1)
- malaria projection (1)
- male bees (1)
- malignant MCA infarct (1)
- malignant glaucoma (1)
- malignant melanoma (1)
- malignant pleural mesothelioma (1)
- mammalian CRY1 (1)
- mammalian cells (1)
- mammographic density (1)
- marathon running (1)
- marine sponge (1)
- markers (1)
- masked priming (1)
- mass spectometry (1)
- mast cells (1)
- matrix metalloproteinase (1)
- matrix metalloproteinases (1)
- maxillary sinus (1)
- mean σ(C–C) = 0.003 Å (1)
- mean σ(C–C) = 0.004 Å (1)
- measles virus (1)
- mechanism (1)
- mechanismofaction (1)
- mediated apoptosis (1)
- medicine (1)
- megavoltage computed-tomography (1)
- melatonin (1)
- memory (1)
- memory suppression (1)
- meningococcal disease (1)
- mesenchymal cells (1)
- mesenchymal tissues (1)
- mesh augmentation (1)
- mesh repair (1)
- metabolic flux (1)
- metabolism (1)
- metacestode vesicles (1)
- metagenomics (1)
- metallurgical characterization (1)
- methane emissions (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- methyl-bromide (1)
- methylation (1)
- methylene blue (1)
- methylphenidate (1)
- miR-22 (1)
- miRNA (1)
- mices (1)
- microRNAs (1)
- microangiopathy (1)
- microarrays (1)
- microdeletion (1)
- microdomains (1)
- microscopy (1)
- microvascular density (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- microvessel permeability (1)
- mimecan (1)
- mimicry (1)
- minimal inhibitory concentration (1)
- mirrorneuronsystem (1)
- mismatch negativity mmn (1)
- mitochondria (1)
- mitochondrial dysfunction (1)
- modelo PBPK/PBTK (1)
- models (1)
- modules (1)
- molecular epidemiology (1)
- molecular genetics (1)
- molecular systematics (1)
- molybdenum cofactor biosynthesis (1)
- momentum scale (1)
- monoamine transporters (1)
- monocycline (1)
- monolayer graphite (1)
- mononuclear phagocytes (1)
- monozygotic twins (1)
- morphogenetic protein (1)
- moth manduca sexta (1)
- motility (1)
- motoneurons (1)
- motor function (1)
- motor preparation (1)
- motor-neuron protein (1)
- mouse (1)
- movement ecology (1)
- movements (1)
- mulitple-sclerosis patients (1)
- multicenter (1)
- multicomponent Ugi-type reaction (1)
- multifactorial (1)
- multiflora (1)
- multijet event (1)
- multilocularis (1)
- multiparticle collision dynamics (1)
- multiple myeloma (1)
- multiple system atrophy (1)
- multiple-sclerosis (1)
- muon decay channel (1)
- muon reconstruction efficiency (1)
- muon spectrometer (1)
- mushroom bodies (1)
- music (1)
- mutant mice (1)
- myasthenia gravis (1)
- mycobacterium-tuberculosis (1)
- myelin (1)
- myelination (1)
- myoelectric activity (1)
- myosin-VI (1)
- nanographenes (1)
- nasal cancer (1)
- nasal lavage (1)
- nasal snuff (1)
- nasal spray (1)
- nasopharyngeal carcinoma (1)
- nasopharyngeal colonization (1)
- natural history (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- neisseria meningitidis (1)
- neobellieria bullata (1)
- neonates (1)
- nervour system (1)
- nervous system (1)
- nervous-system (1)
- netcar-feeding bats (1)
- neural apoptosis (1)
- neural crest (1)
- neurite outgrowth (1)
- neurobehavioural deficits (1)
- neuroinflammation (1)
- neurons form (1)
- neurorepair (1)
- neuroscience (1)
- neurothrophic factor (1)
- neurovirulence (1)
- neutral Higgs boson (1)
- neutral currents (1)
- neutral loss (1)
- neutrophils (1)
- nickel (1)
- nickel release (1)
- nicotine addiction (1)
- nicotinic acetylcholine-receptors (1)
- nitric oxide synthase (1)
- nitricoxidesynthase (1)
- nonalcoholic steatohepatitis (1)
- noncooperative binding (1)
- noninvasive detection (1)
- nonribosomal peptide synthetase (1)
- noradrenalin (1)
- norepinephrine (1)
- novelty detection (1)
- nuclear envelope (1)
- nuclear lamina (1)
- nuclear organization (1)
- nucleosome (1)
- nucleotide exchange (1)
- nucleotide excision-repair (1)
- nucleus (1)
- nude mice (1)
- nutrient uptake (1)
- nutrients (1)
- nyctalus noctula (1)
- obstructive pulmonary disease (1)
- occupational exposures (1)
- oncolytic virus (1)
- onset (1)
- open reduction (1)
- ophrys heldreichii (1)
- optical coherence tomography (1)
- organic solvents (1)
- organization (1)
- organogenesis (1)
- organometallic complexes (1)
- orthodontic brackets (1)
- oscillator (1)
- osteoblast differentiation (1)
- osteochondral allografts (1)
- osteogenesis imperfecta (1)
- osteoglycin (1)
- osteoporosis (1)
- otitis media (1)
- outer membrane protein (1)
- outer-membrane proteins (1)
- pair invariant mass (1)
- pancreatic cancer (1)
- panic disorder (1)
- panton-valentine leukocidin (1)
- paradigm (1)
- paranasal sinuses (1)
- parastomal hernia (1)
- parathyroid-hormone (1)
- parent-child agreement (1)
- parkinson disease (1)
- pars plana vitrectomy (1)
- partial purification (1)
- particle level jet (1)
- partitioning analysis RPA (1)
- parton shower (1)
- pathogenicity island 2 (1)
- pathophysiology (1)
- pathways (1)
- pea (1)
- pediatric lymphoma (1)
- people (1)
- peptide (1)
- peptides (1)
- percutaneous fixation (1)
- performance liquid-chromatography (1)
- perfusion (1)
- period variability (1)
- persistent ADHD (1)
- pesticides (1)
- pet (1)
- pet dogs (1)
- phagocytosis (1)
- phagosomalescape (1)
- phase variation (1)
- photoemission (1)
- photoinhibition (1)
- photon energy scale (1)
- photoprotection (1)
- photosystem II (1)
- phylogenetic tree (1)
- phylogeny (1)
- physical activity (1)
- pig or swine (1)
- pioglitazone (1)
- pitch (1)
- placebo-controlled (1)
- placebo-controlled trial (1)
- planning (1)
- plant-microbe interaction (1)
- plant–microbe interaction (1)
- plasma cells (1)
- plasmodium falciparum (1)
- platelet adhesion (1)
- platelets (1)
- plexus epithelial-cells (1)
- pluripotent (1)
- pollination (1)
- polyarcylamide gels (1)
- polymavirus (1)
- polymorphism (1)
- polymorphisms (1)
- polyomavirus (1)
- population (1)
- population biology (1)
- positron-emission-tomography (1)
- post-transcriptionalregulation (1)
- posttraumatic-stress-disorder (1)
- pp collision (1)
- pre-messenger RNA (1)
- predation risk (1)
- prediction (1)
- predictivetextentry (1)
- predictors (1)
- pregnancy (1)
- prepulse inhibition (1)
- preterm (1)
- preterm infants (1)
- primary prevention (1)
- primary ventral hernia (1)
- primary-care physicians (1)
- probes (1)
- processing deficits (1)
- producation cross section (1)
- production cross section (1)
- progenitor cells (1)
- prognostic index (1)
- prognostic relevance (1)
- prognostic value (1)
- proliferation (1)
- promoter (1)
- promoter methylation (1)
- propagation (1)
- prophylaxis (1)
- propulsion (1)
- prostate (1)
- prostate cancer (1)
- proteasome (1)
- protein argentine methyltranserase (1)
- protein docking (1)
- protein familiy (1)
- protein subunit (1)
- protein synthesis (1)
- protein-interaction networks (1)
- proteins (1)
- proteinuria (1)
- proteolipid protein gene (1)
- proton (1)
- pseudomas-syringae (1)
- psoas muscle (1)
- psychopathology (1)
- psychosis (1)
- pulmonary embolism (1)
- pulmonary gas-exchange (1)
- pyrococcus furiosus (1)
- pythia parton shower (1)
- quali-chick chimeras (1)
- quality-of-life (1)
- quantitative trait locus (1)
- quantized vortices (1)
- radiation oncology (1)
- radiofrequency ablation (1)
- radiotherapy (1)
- rain forest (1)
- raman spectroscopy (1)
- randomized-trial (1)
- rapidity interval (1)
- rare (1)
- rare decays (1)
- rat (1)
- rat calyx (1)
- rat heart (1)
- rat spinal-cord (1)
- reaction centre (1)
- reactivity (1)
- reading disability (1)
- real-time glucose monitoring (1)
- receptor clustering (1)
- receptor-beta subunits (1)
- receptors (1)
- recolonization (1)
- recombination hotspot (1)
- reconstructed mass spectrum (1)
- reconstruction (1)
- recurrence (1)
- recurrent abdominal wall hernia (1)
- regenerative medicine (1)
- region (1)
- registries (1)
- registry (1)
- regulation (1)
- regulatory RNA (1)
- regulatory T cell (1)
- regulatory T cells (1)
- relative abundance (1)
- releasable suture (1)
- relevance (1)
- renal disease (1)
- renal perfusion (1)
- renewal (1)
- replicating adenovirus (1)
- replicative senescence (1)
- reporter gene (1)
- reproductive medicine (1)
- rescue (1)
- respiratory-distress-syndrome (1)
- response inhibition (1)
- response regulator (1)
- resting tremor (1)
- restricition enzymes (1)
- resummation (1)
- resurgence (1)
- retinal ganglion cells (1)
- retinocochleocerebral (1)
- retroviral infection (1)
- reward (1)
- rheumatoid (1)
- rhizobacteria (1)
- rhythm (1)
- ribonuclease-P (1)
- ribonucleases (1)
- ribosomal RNA (1)
- richtersius coronifer (1)
- risk (1)
- risk assessment (1)
- risk factor (1)
- risk genes (1)
- room temperature (1)
- root (1)
- rotational diffusion (1)
- rs112587690 (1)
- rs12628 (1)
- rules (1)
- rural domain (1)
- sRNA (1)
- safety (1)
- salmonella enterica (1)
- salt lakes (1)
- satellite rainfall products (1)
- sationary phase (1)
- satisfiability problems (1)
- savanna woodland (1)
- scaffolding protein gephyryrin (1)
- scaffolds (1)
- scattering (1)
- scattering amplitudes (1)
- scenarios (1)
- schizosaccaromyces-pombe (1)
- scid mice (1)
- scintigraphy (1)
- secondary cancer (1)
- secondary prevention (1)
- secondary structure (1)
- seed protein concentration (1)
- segmental collapse (1)
- selective attention (1)
- self-rating (1)
- semi-convex hulls (1)
- semi-konvexe Hüllen (1)
- semiconductor microavity (1)
- semiconductors (1)
- senescence (1)
- sensitization (1)
- sensor (1)
- sepsis (1)
- sequence (1)
- sequence alignment (1)
- sequence imaging protocol (1)
- sequential standard model (1)
- sequestration (1)
- serogroup B (1)
- serotonin (1)
- serotonin transporter gene (1)
- set (1)
- severe renal insufficiency (1)
- sexual deception (1)
- sglt1 (1)
- sheep model (1)
- shiitake dermatitis (1)
- shiitake mushrooms (1)
- shiitake-dermatite (1)
- shock (1)
- shock sigma factor (1)
- signal peptides (1)
- signal template (1)
- signals (1)
- simulaed event sample (1)
- simulated event sample (1)
- simulation (1)
- sinonasal cancer (1)
- size (1)
- skeletal overexpression (1)
- skin (1)
- slow cortical potentials (1)
- small RNA (1)
- small noncoding RNAs (1)
- small nucleolar RNAs (1)
- small vessel disease (1)
- smoking (1)
- smoking habits (1)
- smoking-cessation (1)
- social calls (1)
- sodium (1)
- soil macrofauna (1)
- soils/sediments (1)
- solid-phase extraction (1)
- solvent (1)
- somatic mosaicism (1)
- sonic hedghog (1)
- sorbents (1)
- soybean (1)
- sparticle cascade decay (1)
- sparticle pair production (1)
- spatial attention (1)
- spatial cueing (1)
- species composition (1)
- species richness (1)
- species richness estimation (1)
- specification (1)
- spectrofluorimetry (1)
- spectroscopy (1)
- spectrum disorders (1)
- spinal-cord (1)
- spiroplasma (1)
- splicing factor (1)
- spontaneous mouse mutants (1)
- sporadic Parkinson's disease (1)
- squamous cell (1)
- stability (1)
- stage pT1 (1)
- standard heparin (1)
- states (1)
- stationary phase (1)
- steady state (1)
- stent (1)
- still-face (1)
- stocks (1)
- strain (1)
- strain MC58 (1)
- stranded DNAs (1)
- strategies (1)
- strategy (1)
- streptozotocin (1)
- stress perfusion (1)
- stroke therapy (1)
- stromal cells (1)
- subacute sclerosing-panencephalitis (1)
- subpopulation (1)
- substantia nigra (1)
- subunit (1)
- summer rainfall (1)
- superoxide-dismutase (1)
- superresolution (1)
- supersymmetric standard model (1)
- supersymmetry (1)
- supersymmetry phenomenology (1)
- surface analysis (1)
- surfactant (1)
- surfactant protein-A (1)
- surrogate endpoints (1)
- survivin (1)
- survivin T-cell reactivity (1)
- survivors (1)
- susceptibility (1)
- susceptibility loci (1)
- swiss model (1)
- symmetry breaking (1)
- symptoms (1)
- synapse formation (1)
- synaptic inhibition (1)
- synechocystis (1)
- synthesis (1)
- synthetic biology (1)
- synthetic surfactant (1)
- systematic effect (1)
- systems (1)
- tPA (1)
- tandem mass-spectrometry (1)
- tardigrada (1)
- target molecule (1)
- task force (1)
- technology (1)
- teleconnection (1)
- temperature (1)
- temperatures (1)
- temporal order judgments (1)
- temporal-lobe epilepsy (1)
- tergite (1)
- teriparatide (1)
- term memory (1)
- territory infaction (1)
- think/no-think paradigm (1)
- thymus (1)
- tight junctions (1)
- time (1)
- time series (1)
- tissue engineering (1)
- tissue microarray (1)
- tissue-plasminogen activator (1)
- titanium (1)
- to-disc ratio (1)
- top event dilepton invariant mass (1)
- top physics (1)
- top quark (1)
- top quark contribution (1)
- top quark masse (1)
- topology (1)
- total pancreatectomy (1)
- total systematic uncertainty (1)
- toxicity (1)
- toxicocinética (1)
- toxicokinetics (1)
- track data analysis (1)
- track momentum (1)
- track multipilicty (1)
- tracking (1)
- traffic noise (1)
- transcription activation (1)
- transcription factor (1)
- transcription factor MIZ-1 (1)
- transcription factors (1)
- transcription-3 (STAT3) (1)
- transcriptional regulator (1)
- transcriptome (1)
- transcriptomeanalysis (1)
- transcutaneous (1)
- transduction (1)
- transgenic mouse model (1)
- transient ischemic attack (1)
- transistors (1)
- transitional cell carcinoma (1)
- translation (1)
- translational initiation (1)
- translational research (1)
- translocation (1)
- transverse momentum momentum spectrum (1)
- transverse momentum vector (1)
- transverse plane (1)
- tremor (1)
- trinervitermes (1)
- tropical North-Africa (1)
- true diversity (1)
- trypanosome lytic factor (1)
- tryptophan (1)
- tube formation (1)
- tuberculous meningitis (1)
- tumor microenvironment (1)
- tumor necrosis factor (1)
- tumor specific antigen (1)
- tumor subtypes (1)
- tumor suppressor (1)
- tumor-draining lymph node (1)
- tumor-necrosis-factor (1)
- typification (1)
- tyrosine kinase (1)
- tyrosine phosphorylation (1)
- ultrasoft pseudopotentials (1)
- ultrastructure (1)
- umbilical hernia (1)
- unconscious processing (1)
- unconverted photon (1)
- underlying event tune (1)
- unfractionated heparin (1)
- univentricular heart (1)
- unpaired median neurons (1)
- up regulation (1)
- upside-down faces (1)
- urothelial bladder carcinoma (1)
- user-centered (1)
- utilization distributions (1)
- vaccination (1)
- vaccine (1)
- vaccines (1)
- vaccinia virus (1)
- validation region (1)
- validity (1)
- variant genotypes (1)
- vascular dementia (1)
- vasculopathy (1)
- ventilation (1)
- ventral hernia (1)
- ventral hernia model (1)
- ventricular tachycardia (1)
- vibrio cholerae (1)
- vicinal surfaces (1)
- viral therapy (1)
- virotherapy (1)
- virus-induced encephalitis (1)
- visceral leishmaniasis (1)
- viscosity (1)
- visual-evoked potentials (1)
- vitamin C (1)
- vitamin-D-receptor (1)
- vitellogenin (1)
- vivo (1)
- voltage dependent (1)
- volume determination (1)
- von Willebrand factor (1)
- voxel-based morphometry (1)
- wR factor = 0.038 (1)
- wR factor = 0.052 (1)
- waking states (1)
- walking (1)
- water channels (1)
- water load test (1)
- water stress (1)
- well (1)
- whole-brain radiotherapy (1)
- wires (1)
- women (1)
- wood dust (1)
- work bee (1)
- worker bee larva (1)
- young work bee (1)
- β-APP (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (51)
- Fakultät für Physik und Astronomie (38)
- Neurologische Klinik und Poliklinik (21)
- Institut für Psychologie (20)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (18)
- Institut für Molekulare Infektionsbiologie (17)
- Medizinische Klinik und Poliklinik I (13)
- Institut für Virologie und Immunbiologie (12)
- Kinderklinik und Poliklinik (10)
- Klinik und Poliklinik für Strahlentherapie (10)
Sonstige beteiligte Institutionen
Purpose: Preclinical experiments on large animals are indispensable for evaluating the effectiveness of diabetes therapies. Miniature swine are well suited for such studies due to their physiological and pathophysiological responses. Methods: We compare two methods for inducing diabetes in Goettingen minipigs (GMP), in five with the beta cell toxin streptozotocin (STZ) and in five other GMP by total pancreatectomy (PE). Glucose homeostasis was assessed with the intravenous glucose-tolerance test (IVGTT) and continual monitoring of interstitial glucose levels. At conclusion of the observation period, the pancreata were examined histologically. Three non-diabetic GMP served as control group. Results: The IVGTT revealed markedly diabetic profiles in both GMP groups. STZ-GMP were found to harbor residual C-peptides and scattered insulin-positive cells in the pancreas. PE-GMP survived the total pancreatectomy only with intensive postoperative care. Conclusions: Although both methods reliably induced diabetes in GMP, the PE-GMP clearly had more health problems and required a greater expenditure of time and resources. The PE-GMP model, however, was better at eliminating endogenous insulin and C-peptide than the STZ-GMP model.
Oncolytic viruses refer to those that are able to eliminate malignancies by direct targeting and lysis of cancer cells, leaving non-cancerous tissues unharmed. Several oncolytic viruses including adenovirus strains, canine distemper virus and vaccinia virus strains have been used for canine cancer therapy in preclinical studies. However, in contrast to human studies, clinical trials with oncolytic viruses for canine cancer patients have not been reported. An ‘ideal’ virus has yet to be identified. This review is focused on the prospective use of oncolytic viruses in the treatment of canine tumors - a knowledge that will undoubtedly contribute to the development of oncolytic viral agents for canine cancer therapy in the future.
Background: Tardigrades are multicellular organisms, resistant to extreme environmental changes such as heat, drought, radiation and freezing. They outlast these conditions in an inactive form (tun) to escape damage to cellular structures and cell death. Tardigrades are apparently able to prevent or repair such damage and are therefore a crucial model organism for stress tolerance. Cultures of the tardigrade Milnesium tardigradum were dehydrated by removing the surrounding water to induce tun formation. During this process and the subsequent rehydration, metabolites were measured in a time series by GC-MS. Additionally expressed sequence tags are available, especially libraries generated from the active and inactive state. The aim of this integrated analysis is to trace changes in tardigrade metabolism and identify pathways responsible for their extreme resistance against physical stress. Results: In this study we propose a novel integrative approach for the analysis of metabolic networks to identify modules of joint shifts on the transcriptomic and metabolic levels. We derive a tardigrade-specific metabolic network represented as an undirected graph with 3,658 nodes (metabolites) and 4,378 edges (reactions). Time course metabolite profiles are used to score the network nodes showing a significant change over time. The edges are scored according to information on enzymes from the EST data. Using this combined information, we identify a key subnetwork (functional module) of concerted changes in metabolic pathways, specific for de- and rehydration. The module is enriched in reactions showing significant changes in metabolite levels and enzyme abundance during the transition. It resembles the cessation of a measurablemetabolism (e.g. glycolysis and amino acid anabolism) during the tun formation, the production of storage metabolites and bioprotectants, such as DNA stabilizers, and the generation of amino acids and cellular components from monosaccharides as carbon and energy source during rehydration. Conclusions: The functional module identifies relationships among changed metabolites (e.g. spermidine) and reactions and provides first insights into important altered metabolic pathways. With sparse and diverse data available, the presented integrated metabolite network approach is suitable to integrate all existing data and analyse it in a combined manner.
We review the particle physics ingredients affecting the normalization, shape, and flavor composition of astrophysical neutrinos fluxes, such as different production modes, magnetic field effects on the secondaries muons, pions, and kaons, and flavor mixing, where we focus on p? interactions. We also discuss the interplay with neutrino propagation and detection, including the possibility to detect flavor and its application in particle physics, and the use of the Glashow resonance to discriminate p? from pp interactions in the source. We illustrate the implications on fluxes and flavor composition with two different models: 1 the target photon spectrum is dominated by synchrotron emission of coaccelerated electrons and 2 the target photon spectrum follows the observed photon spectrum of gamma-ray bursts. In the latter case, the multimessenger extrapolation from the gamma-ray fluence to the expected neutrino flux is highlighted.
Myc is a global transcriptional regulator and one of the most frequently overexpressed oncoproteins in human tumors. It is well established that activation of Myc leads to enhanced cell proliferation but can also lead to increased apoptosis. The use of animal models expressing deregulated levels of Myc has helped to both elucidate its function in normal cells and give insight into how Myc initiates and maintains tumorigenesis. Analyses of the medaka (Oryzias latipes) genome uncovered the unexpected presence of two Myc gene copies in this teleost species. Comparison of these Myc versions to other vertebrate species revealed that one gene, myc17, differs by the loss of some conserved regulatory protein motifs present in all other known Myc genes. To investigate how such differences might affect the basic biological functions of Myc, we generated a tamoxifeninducible in vivo model utilizing a natural, fish-specific Myc gene. Using this model we show that, when activated, Myc17 leads to increased proliferation and to apoptosis in a dose-dependent manner, similar to human Myc. We have also shown that long-term Myc17 activation triggers liver hyperplasia in adult fish, allowing this newly established transgenic medaka model to be used to study the transition from hyperplasia to liver cancer and to identify Myc-induced tumorigenesis modifiers.
Biallelic mutations in MCPH1 cause primary microcephaly (MCPH) with the cellular phenotype of defective chromosome condensation. MCPH1 encodes a multifunctional protein that notably is involved in brain development, regulation of chromosome condensation, and DNA damage response. In the present studies, we detected that MCPH1 encodes several distinct transcripts, including two major forms: full-length MCPH1 (MCPH1-FL) and a second transcript lacking the six 39 exons (MCPH1De9–14). Both variants show comparable tissue-specific expression patterns, demonstrate nuclear localization that is mediated independently via separate NLS motifs, and are more abundant in certain fetal than adult organs. In addition, the expression of either isoform complements the chromosome condensation defect found in genetically MCPH1-deficient or MCPH1 siRNA-depleted cells, demonstrating a redundancy of both MCPH1 isoforms for the regulation of chromosome condensation. Strikingly however, both transcripts are regulated antagonistically during cell-cycle progression and there are functional differences between the isoforms with regard to the DNA damage response; MCPH1-FL localizes to phosphorylated H2AX repair foci following ionizing irradiation, while MCPH1De9–14 was evenly distributed in the nucleus. In summary, our results demonstrate here that MCPH1 encodes different isoforms that are differentially regulated at the transcript level and have different functions at the protein level.
Nephrogenic Systemic Fibrosis is a rare condition appearing only in patients with severe renal impairment or failure and presents with dermal lesions and involvement of internal organs. Although many cases are mild, an estimated 5 % have a progressive debilitating course. To date, there is no known effective treatment thus stressing the necessity of ample prevention measures. An association with the use of Gadolinium based contrast agents (GBCA) makes Nephrogenic Systemic Fibrosis a potential side effect of contrast enhanced magnetic resonance imaging and offers the opportunity for prevention by limiting use of gadolinium based contrast agents in renal failure patients. In itself toxic, Gadolinium is embedded into chelates that allow its safe use as a contrast agent. One NSF theory is that Gadolinium chelates distribute into the extracellular fluid compartment and set Gadolinium ions free, depending on multiple factors among which the duration of chelates exposure is directly related to the renal function. Major medical societies both in Europe and in North America have developed guidelines for the usage of GBCA. Since the establishment of these guidelines and the increased general awareness of this condition, the occurrence of NSF has been nearly eliminated. Giving an overview over the current knowledge of NSF pathobiochemistry, pathogenesis and treatment options this review focuses on the guidelines of the European Medicines Agency, the European Society of Urogenital Radiology, the FDA and the American College of Radiology from 2008 up to 2011 and the transfer of this knowledge into every day practice.
Background: The European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) established an Internet forum which provides the opportunity for CF patients and other interested people to ask experts questions about CF in their mother language. The objectives of this study were to: 1) develop a detailed quality assessment tool to analyze quality of expert answers, 2) evaluate the intra- and inter-rater agreement of this tool, and 3) explore changes in the quality of expert answers over the time frame of the project. Methods: The quality assessment tool was developed by an expert panel. Five experts within the ECORN-CF project used the quality assessment tool to analyze the quality of 108 expert answers published on ECORN-CF from six language zones. 25 expert answers were scored at two time points, one year apart. Quality of answers was also assessed at an early and later period of the project. Individual rater scores and group mean scores were analyzed for each expert answer. Results: A scoring system and training manual were developed analyzing two quality categories of answers: content and formal quality. For content quality, the grades based on group mean scores for all raters showed substantial agreement between two time points, however this was not the case for the grades based on individual rater scores. For formal quality the grades based on group mean scores showed only slight agreement between two time points and there was also poor agreement between time points for the individual grades. The inter-rater agreement for content quality was fair (mean kappa value 0.232 ± 0.036, p < 0.001) while only slight agreement was observed for the grades of the formal quality (mean kappa value 0.105 ± 0.024, p < 0.001). The quality of expert answers was rated high (four language zones) or satisfactory (two language zones) and did not change over time. Conclusions: The quality assessment tool described in this study was feasible and reliable when content quality was assessed by a group of raters. Within ECORN-CF, the tool will help ensure that CF patients all over Europe have equal possibility of access to high quality expert advice on their illness.
We study the symmetrised rank-one convex hull of monoclinic-I martensite (a twelve-variant material) in the context of geometrically-linear elasticity. We construct sets of T3s, which are (non-trivial) symmetrised rank-one convex hulls of 3-tuples of pairwise incompatible strains. Moreover we construct a five-dimensional continuum of T3s and show that its intersection with the boundary of the symmetrised rank-one convex hull is four-dimensional. We also show that there is another kind of monoclinic-I martensite with qualitatively different semi-convex hulls which, so far as we know, has not been experimentally observed. Our strategy is to combine understanding of the algebraic structure of symmetrised rank-one convex cones with knowledge of the faceting structure of the convex polytope formed by the strains.
The nothotaxa of the genus Sedum series Rupestria Berger (Crassulaceae) are reviewed, three new hybrids (S. ×affomarcoi, S. ×henkii and S. ×pascalianum) are described and Sedum brevierei Chass. is typified. The identity of the western (French) populations of S. rupestre L. subsp. erectum ‘t Hart is also clarified, and a table with all known combinations is given.
Background: Sorbents have been shown to adsorb iodinated radiocontrast media. Objective: In this study we describe a simple method to compare various sorbents in terms of capacity to adsorb radiocontrast media. Methods: Iodixanol solution was injected into columns filled with three types of sorbent at filtration velocities of increasing magnitude. Two variables of interest – contrast removal rate and matched iodine retention (MIR) – were calculated to measure the adsorption efficiency and the mass of contrast iodine adsorbed versus sorbent used, respectively. Results: The highest contrast removal and MIR for Porapak Q, CST 401 and Amberlite XAD4 were 41, 38 and 16% (p = 0.22 and 0.0005 for comparisons between Porapak Q-CST 401 and CST 401-Amberlite XAD4) and 0.060, 0.055 and 0.024, respectively (p = 0.18 and 0.0008). Extrapolation to a clinical scenario may suggest that removal of 8 ml iodixanol could be achieved by masses of sorbents of 43, 47 and 107 g, respectively. Conclusion: In this study we set a benchmark for comparing the radiocontrast-adsorbing efficiency of polymer sorbents during first-pass experiments, using a readily available methodology.
During stroke the blood–brain barrier (BBB) is damaged which can result in vasogenic brain edema and inflammation. The reduced blood supply leads to decreased delivery of oxygen and glucose to affected areas of the brain. Oxygen and glucose deprivation (OGD) can cause upregulation of glucose uptake of brain endothelial cells. In this letter, we investigated the influence of MK801, a non-competitive inhibitor of the NMDA-receptor, on the regulation of the glucose uptake and of the main glucose transporters glut1 and sglt1 in murine BBB cell line cerebEND during OGD. mRNA expression of glut1 was upregulated 68.7- fold after 6 h OGD, which was significantly reduced by 10 μM MK801 to 28.9-fold. Sglt1 mRNA expression decreased during OGD which was further reduced by MK801. Glucose uptake was significantly increased up to 907% after 6 h OGD and was still higher (210%) after the 20 h reoxygenation phase compared to normoxia. Ten micromolar MK801 during OGD was able to reduce upregulated glucose uptake after OGD and reoxygenation significantly. Presence of several NMDAR subunits was proven on the mRNA level in cerebEND cells. Furthermore, it was shown that NMDAR subunit NR1 was upregulated during OGD and that this was inhibitable by MK801. In conclusion, the addition of MK801 during the OGD phase reduced significantly the glucose uptake after the subsequent reoxygenation phase in brain endothelial cells.
Previous studies consistently reported abnormal recognition of facial expressions in depression. However, it is still not clear whether this abnormality is due to an enhanced or impaired ability to recognize facial expressions, and what underlying cognitive systems are involved. The present study aimed to examine how individuals with elevated levels of depressive symptoms differ from controls on facial expression recognition and to assess attention and information processing using eye tracking. Forty participants (18 with elevated depressive symptoms) were instructed to label facial expressions depicting one of seven emotions. Results showed that the high-depression group, in comparison with the low-depression group, recognized facial expressions faster and with comparable accuracy. Furthermore, the high-depression group demonstrated greater leftwards attention bias which has been argued to be an indicator of hyperactivation of right hemisphere during facial expression recognition.
Magnetic resonance imaging can be used for preprocedural assessment of complex anatomy for radiofrequency (RF) ablations, e.g., in a univentricular heart. This case report features the treatment of a young patient with a functionally univentricular heart who suffered from persistent sudden onset tachycardia with wide complexes that required RF ablation as treatment.
Unlike other organs the nervous system is secluded from the rest of the organism by the blood brain barrier (BBB) or blood nerve barrier (BNB) preventing passive influx of fluids from the circulation. Similarly, leukocyte entry to the nervous system is tightly controlled. Breakdown of these barriers and cellular inflammation are hallmarks of inflammatory as well as ischemic neurological diseases and thus represent potential therapeutic targets. The spatiotemporal relationship between BBB/BNB disruption and leukocyte infiltration has been a matter of debate. We here review contrast-enhanced magnetic resonance imaging (MRI) as a non-invasive tool to depict barrier dysfunction and its relation to macrophage infiltration in the central and peripheral nervous system under pathological conditions. Novel experimental contrast agents like Gadofluorine M (Gf) allow more sensitive assessment of BBB dysfunction than conventional Gadolinium (Gd)-DTPA enhanced MRI. In addition, Gf facilitates visualization of functional and transient alterations of the BBB remote from lesions. Cellular contrast agents such as superparamagnetic iron oxide particles (SPIO) and perfluorocarbons enable assessment of leukocyte (mainly macrophage) infiltration by MR technology. Combined use of these MR contrast agents disclosed that leukocytes can enter the nervous system independent from a disturbance of the BBB, and vice versa, a dysfunctional BBB/BNB by itself is not sufficient to attract inflammatory cells from the circulation. We will illustrate these basic imaging findings in animal models of multiple sclerosis, cerebral ischemia, and traumatic nerve injury and review corresponding findings in patients.
Staphylococcus aureus uses a plethora of virulence factors to accommodate a diversity of niches in its human host. Aside from the classical manifestations of S. aureus-induced diseases, the pathogen also invades and survives within mammalian host cells. The survival strategies of the pathogen are as diverse as strains or host cell types used. S. aureus is able to replicate in the phagosome or freely in the cytoplasm of its host cells. It escapes the phagosome of professional and non-professional phagocytes, subverts autophagy, induces cell death mechanisms such as apoptosis and pyronecrosis, and even can induce anti-apoptotic programs in phagocytes. The focus of this review is to present a guide to recent research outlining the variety of intracellular fates of S. aureus.
AIM: To study short dsRNA oligonucleotides (siRNA) as a potent tool for artificially modulating gene expression of N-Myc down regulated gene 1 (NDRG1) gene induced under different physiological conditions (Normoxia and hypoxia) modulating NDRG1 transcription, mRNA stability and translation.
METHODS: A cell line established from a patient with glioblastoma multiforme. Plasmid DNA for transfections was prepared with the Endofree Plasmid Maxi kit. From plates containing 5 x 10(7) cells, nuclear extracts were prepared according to previous protocols. The pSUPER-NDRG1 vectors were designed, two sequences were selected from the human NDRG1 cDNA (5'-GCATTATTGGCATGGGAAC-3' and 5'-ATGCAGAGTAACGTGGAAG-3'. reverse transcription polymerase chain reaction was performed using primers designed using published information on -actin and hypoxia-inducible factor (HIF)-1 mRNA sequences in GenBank. NDRG1 mRNA and protein level expression results under different conditions of hypoxia or reoxygenation were compared to aerobic control conditions using the Mann-Whitney U test. Reoxygenation values were also compared to the NDRG1 levels after 24 h of hypoxia (P < 0.05 was considered significant).
RESULTS: siRNA- and iodoacetate (IAA)-mediated downregulation of NDRG1 mRNA and protein expression in vitro in human glioblastoma cell lines showed a nearly complete inhibition of NDRG1 expression when compared to the results obtained due to the inhibitory role of glycolysis inhibitor IAA. Hypoxia responsive elements bound by nuclear HIF-1 in human glioblastoma cells in vitro under different oxygenation conditions and the clearly enhanced binding of nuclear extracts from glioblastoma cell samples exposed to extreme hypoxic conditions confirmed the HIF-1 Western blotting results.
CONCLUSION: NDRG1 represents an additional diagnostic marker for brain tumor detection, due to the role of hypoxia in regulating this gene, and it can represent a potential target for tumor treatment in human glioblastoma. The siRNA method can represent an elegant alternative to modulate the expression of the hypoxia induced NDRG1 gene and can help to monitor the development of the cancer disease treatment outcome through monitoring the expression of this gene in the patients undergoing the different therapeutic treatment alternatives available nowadays.
Emery-Dreifuss muscular dystrophy (EDMD) is a hereditary neuromuscular disorder characterized by slowly progressive muscle weakness, early contractures, and dilated cardiomyopathy. We reported an uneventful general anaesthesia using total intravenous anaesthesia (TIVA) for cardiac transplantation in a 19-year-old woman suffering from EDMD. In vitro contracture test results of two pectoralis major muscle bundles of the patient suggest that exposition to triggering agents does not induce a pathological sarcoplasmic calcium release in the lamin A/C phenotype. However, due to the lack of evidence in the literature, we would recommend TIVA for patients with EDMD if general anaesthesia is required.
INTRODUCTION: Tuberculous meningitis (TM) causes substantial morbidity and mortality in humans. Human TM has been known to be induced by bacteria from the Mycobacterium tuberculosis complex (MTBC), such as M. tuberculosis and M. bovis.
CASE PRESENTATION: We describe a case of meningitis treated with fosfomycin, which showed partial effectiveness in an 80-year-old patient. After a lethal myocardial infarction, M. caprae (MC) was identified in cerebrospinal fluid culture. This isolated acid-fast organism was first identified as MTBC by MTBC-specific PCR (16S rDNA-PCR). Furthermore, species-specific identification of the isolate was done by gyrB PCR-restriction fragment length polymorphism analysis of a part of gyrB DNA. Colony morphology of the isolated MC strain showed dysgonic growth on Lowenstein-Jensen medium. The strain was susceptible to pyrazinamide (PZA).
CONCLUSION: This isolated strain was convincingly identified as MC according to the phenotypic and genotypic characteristics and PZA sensitivity. This is the first report of MC causing TM.
The 7th International Symposium on Neuroprotection and Neurorepair was held from May 2nd to May 5th, 2012 in Potsdam, Germany. The symposium, which directly continues the successful Magdeburg meeting series, attracted over 330 colleagues from 29 countries to discuss recent findings and advances in the field. The focus of the 2012 symposium was widened from stroke and traumatic brain injury to neurodegenerative diseases, notably dementia, and more generally the ageing brain. Thereby, emphasis was given on neurovascular aspects of neurodegeneration and stroke including the blood–brain barrier, recent findings regarding the pathomechanism of Alzheimer’s disease, and brain imaging approaches. In addition, neurobiochemical aspects of neuroprotection, the role of astrogliosis, the clinical progress of cell-based approaches as well as translational hurdles and opportunities were discussed in-depth. This review summarizes some of the most stimulating discussions and reports from the meeting.
BACKGROUND:
Although the repair of ventral abdominal wall hernias is one of the most commonly performed operations, many aspects of their treatment are still under debate or poorly studied. In addition, there is a lack of good definitions and classifications that make the evaluation of studies and meta-analyses in this field of surgery difficult.
MATERIALS AND METHODS:
Under the auspices of the board of the European Hernia Society and following the previously published classifications on inguinal and on ventral hernias, a working group was formed to create an online platform for registration and outcome measurement of operations for ventral abdominal wall hernias. Development of such a registry involved reaching agreement about clear definitions and classifications on patient variables, surgical procedures and mesh materials used, as well as outcome parameters. The EuraHS working group (European registry for abdominal wall hernias) comprised of a multinational European expert panel with specific interest in abdominal wall hernias. Over five working group meetings, consensus was reached on definitions for the data to be recorded in the registry.
RESULTS:
A set of well-described definitions was made. The previously reported EHS classifications of hernias will be used. Risk factors for recurrences and co-morbidities of patients were listed. A new severity of comorbidity score was defined. Post-operative complications were classified according to existing classifications as described for other fields of surgery. A new 3-dimensional numerical quality-of-life score, EuraHS-QoL score, was defined. An online platform is created based on the definitions and classifications, which can be used by individual surgeons, surgical teams or for multicentre studies. A EuraHS website is constructed with easy access to all the definitions, classifications and results from the database.
CONCLUSION:
An online platform for registration and outcome measurement of abdominal wall hernia repairs with clear definitions and classifications is offered to the surgical community. It is hoped that this registry could lead to better evidence-based guidelines for treatment of abdominal wall hernias based on hernia variables, patient variables, available hernia repair materials and techniques.
Epithelial and endothelial cells (EC) are building paracellular barriers which protect the tissue from the external and internal environment. The blood-brain barrier (BBB) consisting of EC, astrocyte end-feet, pericytes and the basal membrane is responsible for the protection and homeostasis of the brain parenchyma. In vitro BBB models are common tools to study the structure and function of the BBB at the cellular level. A considerable number of different in vitro BBB models have been established for research in different laboratories to date. Usually, the cells are obtained from bovine, porcine, rat or mouse brain tissue (discussed in detail in the review by Wilhelm et al. 1). Human tissue samples are available only in a restricted number of laboratories or companies 2,3. While primary cell preparations are time consuming and the EC cultures can differ from batch to batch, the establishment of immortalized EC lines is the focus of scientific interest.
Here, we present a method for establishing an immortalized brain microvascular EC line from neonatal mouse brain. We describe the procedure step-by-step listing the reagents and solutions used. The method established by our lab allows the isolation of a homogenous immortalized endothelial cell line within four to five weeks. The brain microvascular endothelial cell lines termed cEND 4 (from cerebral cortex) and cerebEND 5 (from cerebellar cortex), were isolated according to this procedure in the Förster laboratory and have been effectively used for explanation of different physiological and pathological processes at the BBB. Using cEND and cerebEND we have demonstrated that these cells respond to glucocorticoid- 4,6-9 and estrogen-treatment 10 as well as to pro-infammatory mediators, such as TNFalpha 5,8. Moreover, we have studied the pathology of multiple sclerosis 11 and hypoxia 12,13 on the EC-level. The cEND and cerebEND lines can be considered as a good tool for studying the structure and function of the BBB, cellular responses of ECs to different stimuli or interaction of the EC with lymphocytes or cancer cells.
Multiple fluorescence in situ hybridization is the method of choice for studies aimed at determining simultaneous production of signal transduction molecules and neuromodulators in neurons. In our analyses of the monoamine receptor mRNA expression of peptidergic neurons in the rat telencephalon, double tyramide-signal-amplified fluorescence in situ hybridization delivered satisfactory results for coexpression analysis of neuropeptide Y (NPY) and serotonin receptor 2C (5-HT2C) mRNA, a receptor subtype expressed at high-to-moderate abundance in the regions analyzed. However, expression of 5-HT1A mRNA, which is expressed at comparatively low abundance in many telencephalic areas, could not be unequivocally identified in NPY mRNA-reactive neurons due to high background and poor signal-to-noise ratio in fluorescent receptor mRNA detections. Parallel chromogenic in situ hybridization provided clear labeling for 5-HT1A mRNA and additionally offered the possibility to monitor the chromogen deposition at regular time intervals to determine the optimal signal-to-noise ratio. We first developed a double labeling protocol combining fluorescence and chromogenic in situ hybridization and subsequently expanded this variation to combine double fluorescence and chromogenic in situ hybridization for triple labelings. With this method, we documented expression of 5-HT2C and/or 5-HT1A in subpopulations of telencephalic NPY-producing neurons. The method developed in the present study appears suitable for conventional light and fluorescence microscopy, combines advantages of fluorescence and chromogenic in situ hybridization protocols and thus provides a reliable non-radioactive alternative to previously published multiple labeling methods for coexpression analyses in which one mRNA species requires highly sensitive detection.
Purpose
Once open abdomen therapy has succeeded, the problem of closing the abdominal wall must be addressed. We present a new four-stage procedure involving the application of a two-component mesh and vacuum conditioning for abdominal wall closure of even large defects. The aim is to prevent the development of a giant ventral hernia and the eventual need for the repair of the abdominal wall.
Methods
Nineteen of 62 patients treated by open abdomen over a two-year period could not receive primary abdominal wall closure. To achieve closure in these patients, we applied the following four-stage procedure: stage 1: abdominal damage control and conditioning of the abdominal wall; stage 2: attachment of a tailored two-component mesh of polyglycolic acid (PGA) and large pore polypropylene (PP) in intraperitoneal position (IPOM) plus placement of a vacuum bandage; stage 3: vacuum therapy for 3–4 weeks to allow granulation of the mesh and optimization of dermatotraction; stage 4: final skin suture. During stage 3, eligible patients were weaned from respirator and mobilized.
Results
The abdominal wall gap in the 19 patients ranged in size from 240 cm2 to more than 900 cm2. An average of 3.44 vacuum dressing changes over 19 days were required to achieve 60–100 % granulation of the surface area, so final skin suture could be made. Already in stage 3, 14 patients (73.68 %) could be weaned from respirator an average of 6.78 days after placement of the two-component mesh; 6 patients (31.57 %) could be mobilized on the edge of the bed and/or to a bedside chair after an average of 13 days. No mesh-related hematomas, seromas, or intestinal fistulas were observed.
Conclusion
The four-stage procedure presented here is a viable option for achieving abdominal wall closure in patients treated with open abdomen, enabling us to avoid the development of planned giant ventral hernias. It has few complications and has the special advantage of allowing mobilization of the patients before final skin closure. Long-term course in a large number of patients must still confirm this result.
The present antithrombotic drugs used to treat or prevent ischemic stroke have significant limitations: either they show only moderate efficacy (platelet inhibitors), or they significantly increase the risk for hemorrhages (thrombolytics, anticoagulants). Although most strokes are caused by thrombotic or embolic vessel occlusions, the pathophysiological role of platelets and coagulation is largely unclear. The introduction of novel transgenic mouse models and specific coagulation inhibitors facilitated a detailed analysis of molecular pathways mediating thrombus formation in models of acute ischemic stroke. Prevention of early platelet adhesion to the damaged vessel wall by blocking platelet surface receptors glycoprotein Ib alpha (GPIbα) or glycoprotein VI (GPVI) protects from stroke without provoking bleeding complications. In addition, downstream signaling of GPIbα and GPVI has a key role in platelet calcium homeostasis and activation. Finally, the intrinsic coagulation cascade, activated by coagulation factor XII (FXII), has only recently been identified as another important mediator of thrombosis in cerebrovascular disease, thereby disproving established concepts. This review summarizes the latest insights into the pathophysiology of thrombus formation in the ischemic brain. Potential clinical merits of novel platelet inhibitors and anticoagulants as powerful and safe tools to combat ischemic stroke are discussed.
Aims
Cardiac atrial natriuretic peptide (ANP) participates in the maintenance of arterial blood pressure and intravascular volume homeostasis. The hypovolaemic effects of ANP result from coordinated actions in the kidney and systemic microcirculation. Hence, ANP, via its guanylyl cyclase-A (GC-A) receptor and intracellular cyclic GMP as second messenger, stimulates endothelial albumin permeability. Ultimately, this leads to a shift of plasma fluid into interstitial pools. Here we studied the role of caveolae-mediated transendothelial albumin transport in the hyperpermeability effects of ANP.
Methods and results
Intravital microscopy studies of the mouse cremaster microcirculation showed that ANP stimulates the extravasation of fluorescent albumin from post-capillary venules and causes arteriolar vasodilatation. The hyperpermeability effect was prevented in mice with conditional, endothelial deletion of GC-A (EC GC-A KO) or with deleted caveolin-1 (cav-1), the caveolae scaffold protein. In contrast, the vasodilating effect was preserved. Concomitantly, the acute hypovolaemic action of ANP was abolished in EC GC-A KO and Cav-1−/− mice. In cultured microvascular rat fat pad and mouse lung endothelial cells, ANP stimulated uptake and transendothelial transport of fluorescent albumin without altering endothelial electrical resistance. The stimulatory effect on albumin uptake was prevented in GC-A- or cav-1-deficient pulmonary endothelia. Finally, preparation of caveolin-enriched lipid rafts from mouse lung and western blotting showed that GC-A and cGMP-dependent protein kinase I partly co-localize with Cav-1 in caveolae microdomains.
Conclusion
ANP enhances transendothelial caveolae-mediated albumin transport via its GC-A receptor. This ANP-mediated cross-talk between the heart and the microcirculation is critically involved in the regulation of intravascular volume.
Sexually deceptive orchids mimic signals emitted by female insects in order to attract mate-searching males. Specific attraction of the targeted pollinator is achieved by sex pheromone mimicry, which constitutes the major attraction channel. In close vicinity of the flower, visual signals may enhance attraction, as was shown recently in the sexually deceptive orchid Ophrys heldreichii. Here, we conducted an in situ manipulation experiment in two populations of O. heldreichii on Crete to investigate whether the presence/absence of the conspicuous pink perianth affects reproductive success in two natural orchid populations. We estimated reproductive success of three treatment groups (with intact, removed and artificial perianth) throughout the flowering period as pollinaria removal (male reproductive success) and massulae deposition (female reproductive success). Reproductive success was significantly increased by the presence of a strong visual signal—the conspicuous perianth—in one study population, however, not in the second, most likely due to the low pollinator abundance in the latter population. This study provides further evidence that the coloured perianth in O. heldreichii is adaptive and thus adds to the olfactory signal to maximise pollinator attraction and reproductive success.
Global Regulatory Functions of the Staphylococcus aureus Endoribonuclease III in Gene Expression
(2012)
RNA turnover plays an important role in both virulence and adaptation to stress in the Gram-positive human pathogen Staphylococcus aureus. However, the molecular players and mechanisms involved in these processes are poorly understood. Here, we explored the functions of S. aureus endoribonuclease III (RNase III), a member of the ubiquitous family of double-strand-specific endoribonucleases. To define genomic transcripts that are bound and processed by RNase III, we performed deep sequencing on cDNA libraries generated from RNAs that were co-immunoprecipitated with wild-type RNase III or two different cleavage-defective mutant variants in vivo. Several newly identified RNase III targets were validated by independent experimental methods. We identified various classes of structured RNAs as RNase III substrates and demonstrated that this enzyme is involved in the maturation of rRNAs and tRNAs, regulates the turnover of mRNAs and non-coding RNAs, and autoregulates its synthesis by cleaving within the coding region of its own mRNA. Moreover, we identified a positive effect of RNase III on protein synthesis based on novel mechanisms. RNase III–mediated cleavage in the 5′ untranslated region (5′UTR) enhanced the stability and translation of cspA mRNA, which encodes the major cold-shock protein. Furthermore, RNase III cleaved overlapping 5′UTRs of divergently transcribed genes to generate leaderless mRNAs, which constitutes a novel way to co-regulate neighboring genes. In agreement with recent findings, low abundance antisense RNAs covering 44% of the annotated genes were captured by co-immunoprecipitation with RNase III mutant proteins. Thus, in addition to gene regulation, RNase III is associated with RNA quality control of pervasive transcription. Overall, this study illustrates the complexity of post-transcriptional regulation mediated by RNase III.
During recent years a number of severe clinical syndromes, collectively termed laminopathies, turned out to be caused by various, distinct mutations in the human LMNA gene. Arising from this, remarkable progress has been made to unravel the molecular pathophysiology underlying these disorders. A great benefit in this context was the generation of an A-type lamin deficient mouse line (Lmna\(^{−/−}\)) by Sullivan and others,1 which has become one of the most frequently used models in the field and provided profound insights to many different aspects of A-type lamin function. Here, we report the unexpected finding that these mice express a truncated Lmna gene product on both transcriptional and protein level. Combining different approaches including mass spectrometry, we precisely define this product as a C-terminally truncated lamin A mutant that lacks domains important for protein interactions and post-translational processing. Based on our findings we discuss implications for the interpretation of previous studies using Lmna\(^{−/−}\) mice and the concept of human laminopathies.
Three different types of non-photochemical de-excitation of absorbed light energy protect photosystem II of the sun- and desiccation-tolerant moss Rhytidium rugosum against photo-oxidation. The first mechanism, which is light-induced in hydrated thalli, is sensitive to inhibition by dithiothreitol. It is controlled by the protonation of a thylakoid protein. Other mechanisms are activated by desiccation. One of them permits exciton migration towards a far-red band in the antenna pigments where fast thermal deactivation takes place. This mechanism appears to be similar to a mechanism detected before in desiccated lichens. A third mechanism is based on the reversible photo-accumulation of a radical that acts as a quencher of excitation energy in reaction centres of photosystem II. On the basis of absorption changes around 800 nm, the quencher is suggested to be an oxidized chlorophyll. The data show that desiccated moss is better protected against photo-oxidative damage than hydrated moss. Slow drying of moss thalli in the light increases photo-protection more than slow drying in darkness.
The relationship between asparagine metabolism and protein concentration was investigated in soybean seed. Phenotyping of a population of recombinant inbred lines adapted to Illinois confirmed a positive correlation between free asparagine levels in developing seeds and protein concentration at maturity. Analysis of a second population of recombinant inbred lines adapted to Ontario associated the elevated free asparagine trait with two of four quantitative trait loci determining population variation for protein concentration, including a major one on chromosome 20 (linkage group I) which has been reported in multiple populations. In the seed coat, levels of asparagine synthetase were high at 50 mg and progressively declined until 150 mg seed weight, suggesting that nitrogenous assimilates are pre-conditioned at early developmental stages to enable a high concentration of asparagine in the embryo. The levels of asparaginase B1 showed an opposite pattern, being low at 50 mg and progressively increased until 150 mg, coinciding with an active phase of storage reserve accumulation. In a pair of genetically related cultivars, ∼2-fold higher levels of asparaginase B1 protein and activity in seed coat, were associated with high protein concentration, reflecting enhanced flux of nitrogen. Transcript expression analyses attributed this difference to a specific asparaginase gene, ASPGB1a. These results contribute to our understanding of the processes determining protein concentration in soybean seed.
Technical features of a novel multi-color pulse amplitude modulation (PAM) chlorophyll fluorometer as well as the applied methodology and some typical examples of its practical application with suspensions of Chlorella vulgaris and Synechocystis PCC 6803 are presented. The multi-color PAM provides six colors of pulse-modulated measuring light (peak-wavelengths at 400, 440, 480, 540, 590, and 625 nm) and six colors of actinic light (AL), peaking at 440, 480, 540, 590, 625 and 420–640 nm (white). The AL can be used for continuous illumination, maximal intensity single-turnover pulses, high intensity multiple-turnover pulses, and saturation pulses. In addition, far-red light (peaking at 725 nm) is provided for preferential excitation of PS I. Analysis of the fast fluorescence rise kinetics in saturating light allows determination of the wavelength- and sample-specific functional absorption cross section of PS II, Sigma(II)λ, with which the PS II turnover rate at a given incident photosynthetically active radiation (PAR) can be calculated. Sigma(II)λ is defined for a quasi-dark reference state, thus differing from σPSII used in limnology and oceanography. Vastly different light response curves for Chlorella are obtained with light of different colors, when the usual PAR-scale is used. Based on Sigma(II)λ the PAR, in units of μmol quanta/(m2 s), can be converted into PAR(II) (in units of PS II effective quanta/s) and a fluorescence-based electron transport rate ETR(II) = PAR(II) · Y(II)/Y(II)max can be defined. ETR(II) in contrast to rel.ETR qualifies for quantifying the absolute rate of electron transport in optically thin suspensions of unicellular algae and cyanobacteria. Plots of ETR(II) versus PAR(II) for Chlorella are almost identical using either 440 or 625 nm light. Photoinhibition data are presented suggesting that a lower value of ETR(II)max with 440 nm possibly reflects photodamage via absorption by the Mn-cluster of the oxygen-evolving complex.
Resolving the physiological mechanisms by which rhizobacteria enhance plant growth is difficult, since many such bacteria contain multiple plant growth-promoting properties. To understand further how the 1-aminocyclopropane-1-carboxylate (ACC) deaminase (ACCd)-containing rhizobacterium Variovorax paradoxus 5C-2 affects plant growth, the flows and partitioning of mineral nutrients and abscisic acid (ABA) and ABA metabolism were studied in pea (Pisum sativum) plants following rhizosphere bacterial inoculation. Although root architecture was not affected, inoculation increased root and shoot biomass, and stomatal conductance, by 20, 15, and 24%, respectively, and increased N, P, K, Ca, and Mg uptake by 16, 81, 50, 46, and 58%, respectively. P deposition in inoculated plant roots was 4.9 times higher than that in uninoculated controls. Rhizobacterial inoculation increased root to shoot xylem flows and shoot to root phloem flows of K by 1.8- and 2.1-fold, respectively. In control plants, major sinks for K deposition were the roots and upper shoot (43% and 49% of total uptake, respectively), while rhizobacterial inoculation increased K distribution to the lower shoot at the expense of other compartments (xylem, phloem, and upper shoot). Despite being unable to metabolize ABA in vitro, V. paradoxus 5C-2 decreased root ABA concentrations and accumulation by 40–60%. Although inoculation decreased xylem ABA flows, phloem ABA flows increased. Whether bacterial ACCd attenuates root to shoot ABA signalling requires further investigation, since ABA is critical to maintain growth of droughted plants, and ACCd-containing organisms have been advocated as a means of minimizing growth inhibition of plants in drying soil.
The harlequin ladybird beetle Harmonia axyridis has been introduced in many countries as a biological control agent, but has become an invasive species threatening the biodiversity of native ladybirds. Its invasive success has been attributed to its vigorous resistance against diverse pathogens. This study demonstrates that harmonine ((17R,9Z)-1,17-diaminooctadec-9-ene), which is present in H. axyridis haemolymph, displays broad-spectrum antimicrobial activity that includes human pathogens. Antibacterial activity is most pronounced against fast-growing mycobacteria and Mycobacterium tuberculosis, and the growth of both chloroquine-sensitive and -resistant Plasmodium falciparum strains is inhibited. Harmonine displays gametocytocidal activity, and inhibits the exflagellation of microgametocytes and zygote formation. In an Anopheles stephensi mosquito feeding model, harmonine displays transmission-blocking activity.
Multiple fluorescence in situ hybridization is the method of choice for studies aimed at determining simultaneous production of signal transduction molecules and neuromodulators in neurons. In our analyses of the monoamine receptor mRNA expression of peptidergic neurons in the rat telencephalon, double tyramide-signal-amplified fluorescence in situ hybridization delivered satisfactory results for coexpression analysis of neuropeptide Y (NPY) and serotonin receptor 2C (5-HT2C) mRNA, a receptor subtype expressed at high-to-moderate abundance in the regions analyzed. However, expression of 5-HT1A mRNA, which is expressed at comparatively low abundance in many telencephalic areas, could not be unequivocally identified in NPY mRNA-reactive neurons due to high background and poor signal-to-noise ratio in fluorescent receptor mRNA detections. Parallel chromogenic in situ hybridization provided clear labeling for 5-HT1A mRNA and additionally offered the possibility to monitor the chromogen deposition at regular time intervals to determine the optimal signal-to-noise ratio. We first developed a double labeling protocol combining fluorescence and chromogenic in situ hybridization and subsequently expanded this variation to combine double fluorescence and chromogenic in situ hybridization for triple labelings. With this method, we documented expression of 5-HT2C and/or 5-HT1A in subpopulations of telencephalic NPY-producing neurons. The method developed in the present study appears suitable for conventional light and fluorescence microscopy, combines advantages of fluorescence and chromogenic in situ hybridization protocols and thus provides a reliable non-radioactive alternative to previously published multiple labeling methods for coexpression analyses in which one mRNA species requires highly sensitive detection.
Agrobacterium species are capable of interkingdom gene transfer between bacteria and plants. The genome of Agrobacterium tumefaciens consists of a circular and a linear chromosome, the At-plasmid and the Ti-plasmid, which harbors bacterial virulence genes required for tumor formation in plants. Little is known about promoter sequences and the small RNA (sRNA) repertoire of this and other α-proteobacteria. We used a differential RNA sequencing (dRNA-seq) approach to map transcriptional start sites of 388 annotated genes and operons. In addition, a total number of 228 sRNAs was revealed from all four Agrobacterium replicons. Twenty-two of these were confirmed by independent RNA gel blot analysis and several sRNAs were differentially expressed in response to growth media, growth phase, temperature or pH. One sRNA from the Ti-plasmid was massively induced under virulence conditions. The presence of 76 cis-antisense sRNAs, two of them on the reverse strand of virulence genes, suggests considerable antisense transcription in Agrobacterium. The information gained from this study provides a valuable reservoir for an in-depth understanding of sRNA-mediated regulation of the complex physiology and infection process of Agrobacterium.
The objective of this study was to use data from a noninterventional study to evaluate the effectiveness of adalimumab in rheumatoid arthritis (RA) patients during routine clinical practice and to explore the potential impact of patient and disease characteristics in response to adalimumab therapy. A total of 2,625 RA patients with specified data at baseline (prior to initiating adalimumab treatment) and 12 months entered this study between April 2003 and March 2009. We evaluated response to adalimumab therapy and conducted stepwise regression and subgroup analyses of factors influencing therapeutic response. During the 1-year adalimumab treatment period, disease activity decreased from a baseline mean disease activity score-28 joints (DAS28) of 5.9–3.9, while functional capacity improved from 59.0 to 68.4 Funktionsfragebogen Hannover (FFbH) percentage points. In multivariate regression models, high baseline DAS28 was the strongest positive predictor for decrease in disease activity, and high baseline functional capacity was associated with reduced gains in functional capacity. Male gender was a positive predictor of therapeutic response for both disease activity and functional capacity, while older age and multiple previous biologics were associated with a reduced therapeutic response. Subset analyses provided further support for the impact of baseline DAS28, FFbH, and prior biologic therapy on therapeutic response during treatment. We conclude that treatment with adalimumab leads to decreased disease activity and improved function during routine clinical practice. Patients with high disease activity and low functional capacity are particularly benefitted by adalimumab therapy.
MicroRNAs (miRs) are small non- coding RNA molecules controlling a plethora of biological processes such as development, cellular survival and senescence. We here determined miRs differentially regulated during cardiac postnatal development and aging. Cardiac function, morphology and miR expression profiles were determined in neonatal, 4 weeks, 6 months and 19 months old normotensive male healthy C57/Bl6N mice. MiR-22 was most prominently upregulated during cardiac aging. Cardiac expression of its bioinformatically predicted target mimecan (osteoglycin, OGN) was gradually decreased with advanced age. Luciferase reporter assays validated mimecan as a bona fide miR-22 target. Both, miR-22 and its target mimecan were co- expressed in cardiac fibroblasts and smooth muscle cells. Functionally, miR-22 overexpression induced cellular senescence and promoted migratory activity of cardiac fibroblasts. Small interference RNA-mediated silencing of mimecan in cardiac fibroblasts mimicked the miR-22-mediated effects. Rescue experiments revealed that the effects of miR-22 on cardiac fibroblasts were only partially mediated by mimecan. In conclusion, miR-22 upregulation in the aging heart contributed at least partly to accelerated cardiac fibroblast senescence and increased migratory activity. Our results suggest an involvement of miR-22 in age-associated cardiac changes, such as cardiac fibrosis.
HRAS belongs to the RAS genes superfamily. RAS genes are important players in several human tumors and the single-nucleotide polymorphism rs12628 has been shown to contribute to the risk of bladder, colon, gastrointestinal, oral, and thyroid carcinoma. We hypothesized that this SNP may affect the risk of cutaneous melanoma as well. HRAS gene contains a polymorphic region (rs112587690), a repeated hexanucleotide -GGGCCT- located in intron 1. Three alleles of this region, P1, P2, and P3, have been identified that contain two, three, and four repeats of the hexanucleotide, respectively. We investigated the clinical impact of these polymorphisms in a case–control study. A total of 141 melanoma patients and 118 healthy donors from the North America Caucasian population were screened for rs12628 and rs112587690 polymorphisms. Genotypes were assessed by capillary sequencing or fragment analysis, respectively, and rs12628 CC and rs112587690 P1P1 genotypes significantly associated with increased melanoma risk (OR = 3.83, p = 0.003; OR = 11.3, p = 0.033, respectively), while rs112587690 P1P3 frequency resulted significantly higher in the control group (OR = 0.5, p = 0.017). These results suggest that rs12628 C homozygosis may be considered a potential risk factor for melanoma development in the North American population possibly through the linkage to rs112587690.
RATIONALE:
The endocannabinoid (eCB) system is implicated in several psychiatric disorders. Investigating emotional-motivational dysfunctions as underlying mechanisms, a study in humans revealed that in the C385A polymorphism of the fatty acid amide hydrolase (FAAH), the degrading enzyme of the eCB anandamide (AEA), A carriers, who are characterized by increased signaling of AEA as compared to C/C carriers, exhibited reduced brain reactivity towards unpleasant faces and enhanced reactivity towards reward. However, the association of eCB system with emotional-motivational reactivity is complex and bidirectional due to upcoming compensatory processes.
OBJECTIVES:
Therefore, we further investigated the relationship of the FAAH polymorphism and emotional-motivational reactivity in humans.
METHODS:
We assessed the affect-modulated startle, and ratings of valence and arousal in response to higher arousing pleasant, neutral, and unpleasant pictures in 67 FAAH C385A C/C carriers and 45 A carriers.
RESULTS:
Contrarily to the previous functional MRI study, A carriers compared to C/C carriers exhibited an increased startle potentiation and therefore emotional responsiveness towards unpleasant picture stimuli and reduced startle inhibition indicating reduced emotional reactivity in response to pleasant pictures, while both groups did not differ in ratings of arousal and valence.
CONCLUSIONS:
Our findings emphasize the bidirectionality and thorough examination of the eCB system's impact on emotional reactivity as a central endophenotype underlying various psychiatric disorders.
We have studied the responses of honey bees at different life stages (Apis mellifera) to controlled infection with acute bee paralysis virus and have identified the haemolymph of infected larvae and adult worker bees as the compartment where massive propagation of ABPV occurs. Insects respond with a broad spectrum of induced innate immune reactions to bacterial infections, whereas defence mechanisms based on RNA interference play a major role in antiviral immunity. In this study, we have determined that honey bee larvae and adult workers do not produce a humoral immune reaction upon artificial infection with ABPV, in contrast to control individuals challenged with Escherichia coli. ABPV-infected bees produced neither elevated levels of specific antimicrobial peptides (AMPs), such as hymenoptaecin and defensin, nor any general antimicrobial activity, as revealed by inhibition-zone assays. Additionally, adult bees did not generate melanised nodules upon ABPV infection, an important cellular immune function activated by bacteria and viruses in some insects. Challenge of bees with both ABPV and E. coli showed that innate humoral and cellular immune reactions are induced in mixed infections, albeit at a reduced level.
This paper presents measurements of the polarization of W bosons in top quark decays, derived from \(t\overline{t}\) events with missing transverse momentum, one charged lepton and at least four jets, or two charged leptons and at least two jets. Data from pp collisions at a centre-of-mass energy of 7 TeV were collected with the ATLAS experiment at the LHC and correspond to an integrated luminosity of 1.04 fb\(^{−1}\). The measured fractions of longitudinally, left- and right-handed polarization are F\(_0\) = 0.67 ± 0.07, F\(_L\) = 0.32 ± 0.04 and F\(_R\) = 0.01 ± 0.05, in agreement with the Standard Model predictions. As the polarization of the W bosons in top quark decays is sensitive to the Wtb vertex Lorentz structure and couplings, the measurements were used to set limits on anomalous contributions to the Wtb couplings.
A search for a fermiophobic Higgs boson using diphoton events produced in proton-proton collisions at a centre-of-mass energy of √s=7 TeV is performed using data corresponding to an integrated luminosity of 4.9 fb\(^{−1}\) collected by the ATLAS experiment at the Large Hadron Collider. A specific benchmark model is considered where all the fermion couplings to the Higgs boson are set to zero and the bosonic couplings are kept at the Standard Model values (fermiophobic Higgs model). The largest excess with respect to the background-only hypothesis is found at 125.5 GeV, with a local significance of 2.9 standard deviations, which reduces to 1.6 standard deviations when taking into account the look-elsewhere effect. The data exclude the fermiophobic Higgs model in the ranges 110.0–118.0 GeV and 119.5–121.0 GeV at 95 % confidence level.
The results of a search for direct pair production of heavy top-quark partners in 4.7 fb\(^{−1}\) of integrated luminosity from pp collisions at √s=7 TeV collected by the ATLAS detector at the LHC are reported. Heavy top-quark partners decaying into a top quark and a neutral non-interacting particle are searched for in events with two leptons in the final state. No excess above the Standard Model expectation is observed. Limits are placed on the mass of a supersymmetric scalar top and of a spin-1/2 top-quark partner. A spin-1/2 top-quark partner with a mass between 300 GeV and 480 GeV, decaying to a top quark and a neutral non-interacting particle lighter than 100 GeV, is excluded at 95% confidence level.
This letter reports the results of a search for top and bottom squarks from gluino pair production in 4.7 fb\(^{−1}\) of pp collisions at √s=7 TeV using the ATLAS detector at the LHC. The search is performed in events with large missing transverse momentum and at least three jets identified as originating from a b-quark. Exclusion limits are presented for a variety of gluino-mediated models with gluino masses up to 1 TeV excluded.
The measurement of missing transverse momentum in the ATLAS detector, described in this paper, makes use of the full event reconstruction and a calibration based on reconstructed physics objects. The performance of the missing transverse momentum reconstruction is evaluated using data collected in pp collisions at a centre-of-mass energy of 7 TeV in 2010. Minimum bias events and events with jets of hadrons are used from data samples corresponding to an integrated luminosity of about 0.3 nb\(^{−1}\) and 600 nb\(^{−1}\) respectively, together with events containing a Z boson decaying to two leptons (electrons or muons) or a W boson decaying to a lepton (electron or muon) and a neutrino, from a data sample corresponding to an integrated luminosity of about 36 pb\(^{−1}\). An estimate of the systematic uncertainty on the missing transverse momentum scale is presented
A search for the Standard Model Higgs boson in the H→WW(⋆)→ℓνℓνH→WW(⋆)→ℓνℓν (ℓ=e,μℓ=e,μ) decay mode is presented. The search is performed using proton–proton collision data corresponding to an integrated luminosity of 4.7 fb\(^{−1}\) at a centre-of-mass energy of 7 TeV collected during 2011 with the ATLAS detector at the Large Hadron Collider. No significant excess of events over the expected background is observed. An upper bound is placed on the Higgs boson production cross section as a function of its mass. A Standard Model Higgs boson with mass in the range between 133 GeV and 261 GeV is excluded at 95% confidence level, while the expected exclusion range is from 127 GeV to 233 GeV.
Detailed measurements of the electron performance of the ATLAS detector at the LHC are reported, using decays of the Z, W and J/ψ particles. Data collected in 2010 at s√=7 TeV are used, corresponding to an integrated luminosity of almost 40 pb\(^{−1}\). The inter-alignment of the inner detector and the electromagnetic calorimeter, the determination of the electron energy scale and resolution, and the performance in terms of response uniformity and linearity are discussed. The electron identification, reconstruction and trigger efficiencies, as well as the charge misidentification probability, are also presented.
Proton–proton collisions at √s=7 TeV and heavy ion collisions at \(\sqrt{sNN}\)=2.76 TeV were produced by the LHC and recorded using the ATLAS experiment’s trigger system in 2010. The LHC is designed with a maximum bunch crossing rate of 40 MHz and the ATLAS trigger system is designed to record approximately 200 of these per second. The trigger system selects events by rapidly identifying signatures of muon, electron, photon, tau lepton, jet, and B meson candidates, as well as using global event signatures, such as missing transverse energy. An overview of the ATLAS trigger system, the evolution of the system during 2010 and the performance of the trigger system components and selections based on the 2010 collision data are shown. A brief outline of plans for the trigger system in 2011 is presented.
Using inelastic proton-proton interactions at s√=900 GeV and 7 TeV, recorded by the ATLAS detector at the LHC, measurements have been made of the correlations between forward and backward charged-particle multiplicities and, for the first time, between forward and backward charged-particle summed transverse momentum. In addition, jet-like structure in the events is studied by means of azimuthal distributions of charged particles relative to the charged particle with highest transverse momentum in a selected kinematic region of the event. The results are compared with predictions from tunes of the pythia and herwig++ Monte Carlo generators, which in most cases are found to provide a reasonable description of the data.
We present a measurement of two-particle angular correlations in proton- proton collisions at √s=900 GeV and 7 TeV. The collision events were collected during 2009 and 2010 with the ATLAS detector at the Large Hadron Collider using a single-arm minimum bias trigger. Correlations are measured for charged particles produced in the kinematic range of transverse momentum p\(_T\) > 100 MeV and pseudorapidity |η| < 2.5. A complex structure in pseudorapidity and azimuth is observed at both collision energies. Results are compared to PYTHIA 8 and HERWIG++ as well as to the AMBT2B, DW and Perugia 2011 tunes of PYTHIA 6. The data are not satisfactorily described by any of these models.
This letter reports on a search for hypothetical heavy neutrinos, N, and right-handed gauge bosons, W R, in events with high transverse momentum objects which include two reconstructed leptons and at least one hadronic jet. The results were obtained from data corresponding to an integrated luminosity of 2.1 fb\(^{−1}\) collected in proton–proton collisions at √s=7 TeV with the ATLAS detector at the CERN Large Hadron Collider. No excess above the Standard Model background expectation is observed. Excluded mass regions for Majorana and Dirac neutrinos are presented using two approaches for interactions that violate lepton and lepton-flavor numbers. One approach uses an effective operator framework, the other approach is guided by the Left–Right Symmetric Model. The results described in this letter represent the most stringent limits to date on the masses of heavy neutrinos and W\(_R\) bosons obtained in direct searches.
Measurement of τ polarization in W→τν decays with the ATLAS detector in pp collisions at s√=7 TeV
(2012)
In this paper, a measurement of τ polarization in W→τν decays is presented. It is measured from the energies of the decay products in hadronic τ decays with a single final state charged particle. The data, corresponding to an integrated luminosity of 24 pb\(^{−1}\), were collected by the ATLAS experiment at the Large Hadron Collider in 2010. The measured value of the τ polarization is P\(_τ\)=−1.06±0.04 (stat)\(^{+0.05}_{−0.07}\) (syst), in agreement with the Standard Model prediction, and is consistent with a physically allowed 95 % CL interval [−1,−0.91]. Measurements of τ polarization have not previously been made at hadron colliders.
A measurement of event shape variables is presented for large momentum transfer proton-proton collisions using the ATLAS detector at the Large Hadron Collider. Six event shape variables calculated using hadronic jets are studied in inclusive multi-jet events in 35 pb\(^{−1}\) of integrated luminosity at a center-of-mass energy of √s=7 TeV. These measurements are compared to predictions by three Monte Carlo event generators containing leading-logarithmic parton showers matched to leading order matrix elements for 2→2 and 2→n (n=2,…,6) scattering. Measurements of the third-jet resolution parameter, aplanarity, thrust, sphericity, and transverse sphericity are generally well described. The mean value of each event shape variable is evaluated as a function of the average momentum of the two leading jets p\(_{T,1}\) and p\(_{T,2}\), with a mean p\(_T\) approaching 1 TeV.
In models of anomaly-mediated supersymmetry breaking (AMSB), the lightest chargino is predicted to have a lifetime long enough to be detected in collider experiments. This letter explores AMSB scenarios in pp collisions at √s=7 TeV by attempting to identify decaying charginos which result in tracks that appear to have few associated hits in the outer region of the tracking system. The search was based on data corresponding to an integrated luminosity of 1.02 fb\(^{−1}\) collected with the ATLAS detector in 2011. The p\(_T\) spectrum of candidate tracks is found to be consistent with the expectation from Standard Model background processes and constraints on the lifetime and the production cross section were obtained. In the minimal AMSB framework with m\(_{3/2}\)<32 TeV, m\(_0\)<1.5 TeV, tanβ=5 and μ>0, a chargino having mass below 92 GeV and a lifetime between 0.5 ns and 2 ns is excluded at 95 % confidence level.
A search for top quark pair resonances in final states containing at least one electron or muon has been performed with the ATLAS experiment at the CERN Large Hadron Collider. The search uses a data sample corresponding to an integrated luminosity of 2.05 fb\(^{−1}\), which was recorded in 2011 at a proton-proton centre-of-mass energy of 7 TeV. No evidence for a resonance is found and limits are set on the production cross-section times branching ratio to \(t\overline t\) for narrow and wide resonances. For narrow Z′ bosons, the observed 95 % Bayesian credibility level limits range from 9.3 pb to 0.95 pb for masses in the range of m Z′=500 GeV to m\(_{Z′}\)=1300 GeV. The corresponding excluded mass region for a leptophobic topcolour Z′ boson (Kaluza-Klein gluon excitation in the Randall-Sundrum model) is m\(_{Z′}\)<880 GeV (m\(_{gKK}\)<1130 GeV).
Measurement of W\(^{±}\)Z production in proton-proton collisions at √s=7 TeV with the ATLAS detector
(2012)
A study of W\(^{±}\)Z production in proton-proton collisions at √s=7 TeV is presented using data corresponding to an integrated luminosity of 4.6 fb\(^{−1}\) collected with the ATLAS detector at the Large Hadron Collider in 2011. In total, 317 candidates, with a background expectation of 68±10 events, are observed in double-leptonic decay final states with electrons, muons and missing transverse momentum. The total cross-section is determined to be σ\(^{tot}_{WZ}\)=19.0\(^{+1.4}_{−1.3}\)(stat.)±0.9(syst.)±0.4(lumi.) pb, consistent with the Standard Model expectation of 17.6\(^{+1.1}_{−1.0}\) pb. Limits on anomalous triple gauge boson couplings are derived using the transverse momentum spectrum of Z bosons in the selected events. The cross-section is also presented as a function of Z boson transverse momentum and diboson invariant mass.
The ATLAS detector at the Large Hadron Collider is used to search for high-mass resonances decaying to an electron-positron pair or a muon-antimuon pair. The search is sensitive to heavy neutral Z′ gauge bosons, Randall-Sundrum gravitons, Z* bosons, techni-mesons, Kaluza-Klein Z/γ bosons, and bosons predicted by Torsion models. Results are presented based on an analysis of pp collisions at a center-of-mass energy of 7 TeV corresponding to an integrated luminosity of 4.9 fb\(^{−1}\) in the e\(^+\)e\(^−\) channel and 5.0 fb\(^{−1}\) in the μ\(^+\)μ\(^−\)channel. A Z′ boson with Standard Model-like couplings is excluded at 95 % confidence level for masses below 2.22 TeV. A Randall-Sundrum graviton with coupling k/\(\overline M_{Pl}\)=0.1 is excluded at 95 % confidence level for masses below 2.16 TeV. Limits on the other models are also presented, including Technicolor and Minimal Z′ Models.
Search for anomalous production of prompt like-sign lepton pairs at √s=7TeV with the ATLAS detector
(2012)
An inclusive search for anomalous production of two prompt, isolated leptons with the same electric charge is presented. The search is performed in a data sample corresponding to 4.7 fb\(^{−1}\) of integrated luminosity collected in 2011 at √s=7TeV with the ATLAS detector at the LHC. Pairs of leptons (e\(^{±}\)e\(^{±}\), e\(^{±}\)μ\(^{±}\), and μ\(^{±}\)μ\(^{±}\)) with large transverse momentum are selected, and the dilepton invariant mass distribution is examined for any deviation from the Standard Model expectation. No excess is found, and upper limits on the production cross section of like-sign lepton pairs from physics processes beyond the Standard Model are placed as a function of the dilepton invariant mass within a fiducial region close to the experimental selection criteria. The 95% confidence level upper limits on the cross section of anomalous e\(^{±}\)e\(^{±}\), e\(^{±}\)μ\(^{±}\), or μ\(^{±}\)μ\(^{±}\) production range between 1.7 fb and 64 fb depending on the dilepton mass and flavour combination.
This paper describes measurements of the sum of the transverse energy of particles as a function of particle pseudorapidity, η, in proton-proton collisions at a centre-of-mass energy, √s=7 TeV using the ATLAS detector at the Large Hadron Collider. The measurements are performed in the region |η| < 4.8 for two event classes: those requiring the presence of particles with a low transverse momentum and those requiring particles with a significant transverse momentum. In the second dataset measurements are made in the region transverse to the hard scatter. The distributions are compared to the predictions of various Monte Carlo event generators, which generally tend to underestimate the amount of transverse energy at high |η|.
This paper describes an analysis of the angular distribution of W→eν and W→μν decays, using data from pp collisions at s√=7 TeV recorded with the ATLAS detector at the LHC in 2010, corresponding to an integrated luminosity of about 35 pb\(^{−1}\). Using the decay lepton transverse momentum and the missing transverse momentum, the W decay angular distribution projected onto the transverse plane is obtained and analysed in terms of helicity fractions f\(_0\), f\(_L\) and f\(_R\) over two ranges of W transverse momentum (p\(^W_T\)):35<p\(^W_T\)<50 GeV and p\(^W_T\)>50 GeV. Good agreement is found with theoretical predictions. For p\(^W_T\)>50 GeV, the values of f\(_0\) and f\(_L\)−f\(_R\), averaged over charge and lepton flavour, are measured to be: f\(_0\)=0.127±0.030±0.108 and f\(_L\)−f\(_R\)=0.252±0.017±0.030, where the first uncertainties are statistical, and the second include all systematic effects.
Pseudorapidity gap distributions in proton-proton collisions at √s=7 TeV are studied using a minimum bias data sample with an integrated luminosity of 7.1 μb\(^{−1}\). Cross sections are measured differentially in terms of Δη\(^F\), the larger of the pseudorapidity regions extending to the limits of the ATLAS sensitivity, at η=±4.9, in which no final state particles are produced above a transverse momentum threshold pcutT. The measurements span the region 0<Δη\(^F\)<8 for 200MeV<p\(^{cut}_T\)<800MeV. At small Δη\(^F\) , the data test the reliability of hadronisation models in describing rapidity and transverse momentum fluctuations in final state particle production. The measurements at larger gap sizes are dominated by contributions from the single diffractive dissociation process (pp→Xp), enhanced by double dissociation (pp→XY) where the invariant mass of the lighter of the two dissociation systems satisfies M\(_Y\) ≲7 GeV. The resulting cross section is dσ/dΔη\(^F\) ≈1 mb for Δη\(^F\) ≳3. The large rapidity gap data are used to constrain the value of the Pomeron intercept appropriate to triple Regge models of soft diffraction. The cross section integrated over all gap sizes is compared with other LHC inelastic cross section measurements.
This paper presents a search for the t-channel exchange of an R-parity violating scalar top quark ( \(\tilde{t}\) ) in the e\(^±\) μ\(^∓\) continuum using 2.1 fb\(^{−1}\) of data collected by the ATLAS detector in √s=7 TeV pp collisions at the Large Hadron Collider. Data are found to be consistent with the expectation from the Standard Model backgrounds. Limits on R-parity-violating couplings at 95 % C.L. are calculated as a function of the scalar top mass (m\(_\tilde{t}\)). The upper limits on the production cross section for pp→eμX, through the t-channel exchange of a scalar top quark, ranges from 170 fb for m\(_\tilde{t}\)=95 GeV to 30 fb for m\(_\tilde{t}\)=1000 GeV.
Numerous small non-coding RNAs (sRNAs) in bacteria modulate rates of translation initiation and degradation of target mRNAs, which they recognize through base-pairing facilitated by the RNA chaperone Hfq. Recent evidence indicates that the ternary complex of Hfq, sRNA and mRNA guides endoribonuclease RNase E to initiate turnover of both the RNAs. We show that a sRNA not only guides RNase E to a defined site in a target RNA, but also allosterically activates the enzyme by presenting a monophosphate group at the 5′-end of the cognate-pairing “seed.” Moreover, in the absence of the target the 5′-monophosphate makes the sRNA seed region vulnerable to an attack by RNase E against which Hfq confers no protection. These results suggest that the chemical signature and pairing status of the sRNA seed region may help to both ‘proofread’ recognition and activate mRNA cleavage, as part of a dynamic process involving cooperation of RNA, Hfq and RNase E.
Background
Therapeutic vaccination directed to induce an anti-tumoral T-cell response is a field of extensive investigation in the treatment of melanoma. However, many vaccination trials in melanoma failed to demonstrate a correlation between the vaccine-specific immune response and therapy outcome. This has been mainly attributed to immune escape by antigen loss, rendering us in the need of new vaccination targets.
Patients and methods
This phase-II trial investigated a peptide vaccination against survivin, an oncogenic inhibitor-of-apoptosis protein crucial for the survival of tumor cells, in HLA-A1/-A2/-B35-positive patients with treatment-refractory stage-IV metastatic melanoma. The study endpoints were survivin-specific T-cell reactivity (SSTR), safety, response, and survival (OS).
Results
Sixty-one patients (ITT) received vaccination therapy using three different regimens. 55 patients (PP) were evaluable for response and survival, and 41/55 for SSTR. Patients achieving progression arrest (CR + PR + SD) more often showed SSTRs than patients with disease progression (p = 0.0008). Patients presenting SSTRs revealed a prolonged OS (median 19.6 vs. 8.6 months; p = 0.0077); multivariate analysis demonstrated SSTR as an independent predictor of survival (p = 0.013). The induction of SSTRs was associated with gender (female vs. male; p = 0.014) and disease stage (M1a/b vs. M1c; p = 0.010), but not with patient age, HLA type, performance status, or vaccination regimen.
Conclusion
Survivin-specific T-cell reactivities strongly correlate with tumor response and patient survival, indicating that vaccination with survivin-derived peptides is a promising treatment strategy in melanoma.
Bis(μ-diisopropyl-phosphanido-\(κ^2\)P:P)bis-[hydrido(triisopropyl-phosphane-κP)platinum(II)]
(2012)
In the centrosymmetric molecular structure of the title compound \([Pt_2(C_6H_{14}P)_2H_2)(C_9H_{21}P)_2]\), each \(Pt^{II}\) atom is bound on one side to a phosphane ligand \((PiPr_3)\) and a hydrido ligand. On the other side, it is bound to two phosphanide ligands \((μ-PiPr_2)\), which engage a bridging position between the two \(Pt^{II}\) atoms, forming a distorted square-planar structure motif. The PtPt distance is 3.6755(2)Å. A comparable molecular structure was observed for bis-(μ-di-tert-butyl-phosphanido)bis-[hydrido(triethyl-phosphane)platinum(II)] [Itazaki et al. (2004 ). Organometallics, 23, 1610-1621].
BACKGROUND: In the face of growing resistance in malaria parasites to drugs, pharmacological combination therapies are important. There is accumulating evidence that methylene blue (MB) is an effective drug against malaria. Here we explore the biological effects of both MB alone and in combination therapy using modeling and experimental data.
RESULTS: We built a model of the central metabolic pathways in P. falciparum. Metabolic flux modes and their changes under MB were calculated by integrating experimental data (RT-PCR data on mRNAs for redox enzymes) as constraints and results from the YANA software package for metabolic pathway calculations. Several different lines of MB attack on Plasmodium redox defense were identified by analysis of the network effects. Next, chloroquine resistance based on pfmdr/and pfcrt transporters, as well as pyrimethamine/sulfadoxine resistance (by mutations in DHF/DHPS), were modeled in silico. Further modeling shows that MB has a favorable synergism on antimalarial network effects with these commonly used antimalarial drugs.
CONCLUSIONS: Theoretical and experimental results support that methylene blue should, because of its resistance-breaking potential, be further tested as a key component in drug combination therapy efforts in holoendemic areas.
Defects in glycinergic inhibition result in a complex neuromotor disorder in humans known as hyperekplexia (OMIM 149400) with similar phenotypes in rodents characterized by an exaggerated startle reflex and hypertonia. Analogous to genetic defects in humans single point mutations, microdeletions, or insertions in the Glra1 gene but also in the Glrb gene underlie the pathology in mice. The mutations either localized in the (spasmodic, oscillator, cincinnati, Nmf11) or the (spastic) subunit of the glycine receptor (GlyR) are much less tolerated in mice than in humans, leaving the question for the existence of different regulatory elements of the pathomechanisms in humans and rodents. In addition to the spontaneous mutations, new insights into understanding of the regulatory pathways in hyperekplexia or glycine encephalopathy arose from the constantly increasing number of knock-out as well as knock-in mutants of GlyRs. Over the last five years, various efforts using in vivo whole cell recordings provided a detailed analysis of the kinetic parameters underlying glycinergic dysfunction. Presynaptic compensation as well as postsynaptic compensatory mechanisms in these mice by other GlyR subunits or GABA(A) receptors, and the role of extra-synaptic GlyRs is still a matter of debate. A recent study on the mouse mutant oscillator displayed a novel aspect for compensation of functionality by complementation of receptor domains that fold independently. This review focuses on defects in glycinergic neurotransmission in mice discussed with the background of human hyperekplexia en route to strategies of compensation.
Cystic fibrosis (CF) is one of the most common inherited diseases and is caused by mutations in the CFTR gene. Although the pulmonary and gastrointestinal manifestations of the disease remain in the focus of treatment, recent studies have shown expression of the CFTR gene product in skeletal muscle cells and observed altered intramuscular \(Ca^{2+}\) release dynamics in CFTR-deficient animal models. Physical exercise is beneficial for maintaining fitness and well-being in CF patients and constitutes one aspect of modern multimodal treatment, which has considerably increased life span and reduced morbidity. We report on a case of acute muscle trauma resulting from excessive dumbbell exercise in a young adult with cystic fibrosis and describe clinical, laboratory and imaging characteristics of acute exercise-induced muscle injury.
Anticipating where an event will occur enables us to instantaneously respond to events that occur at the expected location. Here we investigated if such spatial anticipations can be triggered by symbolic information that participants cannot consciously see. In two experiments involving a Posner cueing task and a visual search task, a central cue informed participants about the likely location of the next target stimulus. In half of the trials, this cue was rendered invisible by pattern masking. In both experiments, visible cues led to cueing effects, that is, faster responses after valid compared to invalid cues. Importantly, even masked cues caused cueing effects, though to a lesser extent. Additionally, we analyzed effects on attention that persist from one trial to the subsequent trial. We found that spatial anticipations are able to interfere with newly formed spatial anticipations and influence orienting of attention in the subsequent trial. When the preceding cue was visible, the corresponding spatial anticipation persisted to an extent that prevented a noticeable effect of masked cues. The effects of visible cues were likewise modulated by previous spatial anticipations, but were strong enough to also exert an impact on attention themselves. Altogether, the results suggest that spatial anticipations can be formed on the basis of unconscious stimuli, but that interfering influences like still active spatial anticipations can suppress this effect.
Glioblastomas are characterized by an aggressive local growth pattern, a marked degree of invasiveness and poor prognosis. Tumor invasiveness is facilitated by the increased activity of proteolytic enzymes which are involved in destruction of the extracellular matrix of the surrounding healthy brain tissue. Elevated levels of matrix metalloproteinases (MMPs) were found in glioblastoma (GBM) cell-lines, as well as in GBM biopsies as compared with low-grade astrocytoma (LGA) and normal brain samples, indicating a role in malignant progression. A careful review of the available literature revealed that both the expression and role of several of the 23 human MMP proteins is controversely discussed and for some there are no data available at all. We therefore screened a panel of 15 LGA and 15 GBM biopsy samples for those MMPs for which there is either no, very limited or even contradictory data available. Hence, this is the first complete compilation of the expression pattern of all 23 human MMPs in astrocytic tumors. This study will support a better understanding of the specific expression patterns and interaction of proteolytic enzymes in malignant human glioma and may provide additional starting points for targeted patient therapy.
Lymph node metastases associated with prostate cancer (PCa) has been shown to be a poor prognostic factor. The role of pelvic lymph node dissection (PLND) itself in relation to survival remains unclear, however. A Medline search was conducted to address this issue. The following conclusions were drawn. Only recently, improved survival due to completion of radical prostatectomy (RP) (compared to abandoning RP) in known or presumed lymph-node-positive patients has been shown. Lymph node sampling can only be considered representative if an adequate number of nodes is removed. While several authors have suggested that a therapeutic benefit in patients undergoing RP is not provided by PLND, the reliability of these studies is uncertain. Contrary to this, several studies have indicated the possibility of long-term survival even in the presence of limited lymph node metastases. The role and timing of initiation of adjuvant androgen deprivation therapy (ADT) in patients who have node-positive disease after RP is controversial. Recent studies suggest that delaying ADT may not adversely impact survival.
Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant viruses must be avoided because of the direct-antiviral action. Altogether it remains a challenge to take treatment decisions in a clinical setting with cost restrictions. Genetic host factors are hereby essential to implement an individualized treatment concept. In recent years results on different genetic variants have been published with a strong association with therapy response, fibrosis and treatment-related side effects. Polymorphisms of the IL28B gene were identified as accurate predictors for therapy response and spontaneous clearance of HCV infection and are already used for diagnostic decisions. For RBV-induced side effects, such as hemolytic anemia, associations to genetic variants of inosine triphosphatase (ITPA) were described and different SLC28 transporters for RBV-uptake have been successfully analyzed. Fibrosis progression has been associated with variants of Vitamin D receptor (VDR) and ABCB11 (bile salt export pump). Cirrhotic patients especially have a high treatment risk and low therapy response, so that personalized antiviral treatment is mandatory. This review focuses on different host genetic variants in the pathogenesis of Hepatitis C at the beginning of a new area of treatment.
Background: There is increasing evidence that glial cells play a role in the pathomechanisms of mood disorders and the mode of action of antidepressant drugs.
Methods: To examine whether there is a direct effect on the expression of different genes encoding proteins that have been implicated in the pathophysiology of affective disorders, primary astrocyte cell cultures from rats were treated with two different antidepressant drugs, imipramine and escitalopram, and the RNA expression of brain-derived neurotrophic factor (Bdnf), serotonin transporter (5Htt), dopamine transporter (Dat), and endothelial nitric oxide synthase (Nos3) was examined.
Results: Stimulation of astroglial cell culture with imipramine, a tricyclic antidepressant, led to a significant increase of the Bdnf RNA level whereas treatment with escitalopram did not. In contrast, 5Htt was not differentially expressed after antidepressant treatment. Finally, neither Dat nor Nos3 RNA expression was detected in cultured astrocytes.
Conclusion: These data provide further evidence for a role of astroglial cells in the molecular mechanisms of action of antidepressants.
The title compound, \(C_{21}H_{21}O_2PS_2\), was obtained from the corresponding dilithio methandiide by treatment with iodo-methane. The bond lengths and angles deviate considerably from those in the dimetallated compound. These differences are most pronounced in the PCS backbone. While the title compound features C-P and C-S distances of 1.9082(17) and 1.8348(17)Å, respectively, the dianion showed \(C-P_{av}\) distances shortened by 11% [1.710(4)Å] and C-S distances shortened by 12% [1.614(3)Å]. Additionally, the P-C-S angle experiences a contraction by methyl-ation of the dianion from 121.4(2) to 111.96(9)° in the title compound.
Two-component systems (TCS) are short signalling pathways generally occurring in prokaryotes. They frequently regulate prokaryotic stimulus responses and thus are also of interest for engineering in biotechnology and synthetic biology. The aim of this study is to better understand and describe rewiring of TCS while investigating different evolutionary scenarios. Based on large-scale screens of TCS in different organisms, this study gives detailed data, concrete alignments, and structure analysis on three general modification scenarios, where TCS were rewired for new responses and functions: (i) exchanges in the sequence within single TCS domains, (ii) exchange of whole TCS domains; (iii) addition of new components modulating TCS function. As a result, the replacement of stimulus and promotor cassettes to rewire TCS is well defined exploiting the alignments given here. The diverged TCS examples are non-trivial and the design is challenging. Designed connector proteins may also be useful to modify TCS in selected cases.
Incidence rates of infections caused by environmental opportunistic fungi have risen over recent decades. Aspergillus species have emerged as serious threat for the immunecompromised, and detailed knowledge about virulence-determining traits is crucial for drug target identification. As a prime saprobe, A. fumigatus has evolved to efficiently adapt to various stresses and to sustain nutritional supply by osmotrophy, which is characterized by extracellular substrate digestion followed by efficient uptake of breakdown products that are then fed into the fungal primary metabolism. These intrinsic metabolic features are believed to be related with its virulence ability. The plethora of genes that encode underlying effectors has hampered their in-depth analysis with respect to pathogenesis. Recent developments in Aspergillus molecular biology allow conditional gene expression or comprehensive targeting of gene families to cope with redundancy. Furthermore, identification of essential genes that are intrinsically connected to virulence opens accurate perspectives for novel targets in antifungal therapy.
BACKGROUND: The purpose of this study was to compare the outcomes of trabeculectomy using single sutures or releasable sutures.
METHODS: This retrospective study analyzed the medical records of 61 patients who had undergone trabeculectomy using single sutures (n = 33, 54.1%) or releasable sutures (n = 28, 45.9%). The scleral flap was secured with a mean 3.9 (range 3-5) single sutures in 33 patients and with three releasable sutures in 28 patients. Primary outcomes were the success rate, based on intraocular pressure and medication usage, and the frequency of complications and post-surgical interventions. The criteria used to determine complete success were, first, intraocular pressure < 18 mmHg and, second, <=21 mmHg and >=20% intraocular pressure reduction without glaucoma medication.
RESULTS: All patients had an intraocular pressure <= 21 mmHg; 87.5% in the single suture group and 92.6% in the releasable suture group had an intraocular pressure < 18 mmHg at 24 months. There was a highly significant reduction in intraocular pressure to baseline values in both groups at the last visit. Applying the first criterion, complete success was achieved in 57.6% of patients with single sutures and 71.4% with releasable sutures, and based on the second criterion, 66.7% and 71.4%, respectively. No significant difference was found between the groups with regard to intraocular pressure, or success or complication rates.
CONCLUSION: The results of trabeculectomy using single sutures or releasable sutures are equivalent. Therefore, the choice of suture technique should be based on individual patient requirements and surgeon experience.
Background
Blood-born miRNA signatures have recently been reported for various tumor diseases. Here, we compared the miRNA signature in Wilms tumor patients prior and after preoperative chemotherapy according to SIOP protocol 2001.
Results
We did not find a significant difference between miRNA signature of both groups. However both, Wilms tumor patients prior and after chemotherapy showed a miRNA signature different from healthy controls. The signature of Wilms tumor patients prior to chemotherapy showed an accuracy of 97.5% and of patients after chemotherapy an accuracy of 97.0%, each as compared to healthy controls.
Conclusion
Our results provide evidence for a blood-born Wilms tumor miRNA signature largely independent of four weeks preoperative chemotherapy treatment.
Background
Animal models are frequently used to assess new treatment methods in cancer research. MRI offers a non-invasive in vivo monitoring of tumour tissue and thus allows longitudinal measurements of treatment effects, without the need for large cohorts of animals. Tumour size is an important biomarker of the disease development, but to our knowledge, MRI based size measurements have not yet been verified for small tumours (10−2–10−1 g). The aim of this study was to assess the accuracy of MRI based tumour size measurements of small tumours on mice.
Methods
2D and 3D T2-weighted RARE images of tumour bearing mice were acquired in vivo using a 7 T dedicated animal MR system. For the 3D images the acquired image resolution was varied. The images were exported to a PC workstation where the tumour mass was determined assuming a density of 1 g/cm3, using an in-house developed tool for segmentation and delineation. The resulting data were compared to the weight of the resected tumours after sacrifice of the animal using regression analysis.
Results
Strong correlations were demonstrated between MRI- and necropsy determined masses. In general, 3D acquisition was not a prerequisite for high accuracy. However, it was slightly more accurate than 2D when small (<0.2 g) tumours were assessed for inter- and intraobserver variation. In 3D images, the voxel sizes could be increased from 1603 μm3 to 2403 μm3 without affecting the results significantly, thus reducing acquisition time substantially.
Conclusions
2D MRI was sufficient for accurate tumour size measurement, except for small tumours (<0.2 g) where 3D acquisition was necessary to reduce interobserver variation. Acquisition times between 15 and 50 minutes, depending on tumour size, were sufficient for accurate tumour volume measurement. Hence, it is possible to include further MR investigations of the tumour, such as tissue perfusion, diffusion or metabolic composition in the same MR session.
Background
Adequate anticoagulation is prerequisite for effective hemodialysis to prevent clotting in the extracorporeal circuit. We aimed providing first data on the efficacy and safety of the low-molecular-weight heparin certoparin in this setting.
Methods
Multicenter, open-label, 8-week trial. Patients received a single dose of 3,000 IU certoparin i.v. with additional titration steps of 600 IU and/or continuous infusion if necessary.
Results
120 patients were screened, 109 enrolled (median age 71; range 26–90 years) and 106 available for efficacy analyses. The percentage of unsatisfactory dialysis results at 8 weeks due to clotting or bleeding, was 1.9% (n = 2/106; 95% confidence interval [CI] 0.23–6.65%); no major bleeding. 1.9% had moderate/severe clotting in the lines/bubble catcher and 2.8% in the dialyser at week 8. 15.7 ± 14.3% of the dialysis filters’ visual surface area was showing redness. In subgroups of patients receiving median doses of 3000 ± 0, 3000 (2400–6000) and 4200 (3000–6600) IU, plasma aXa levels at baseline, 4 and 8 weeks were 0.24 [95%CI 0.21–0.27], 0.33 [0.27–0.40] and 0.38 [0.33–0.45] aXa IU/ml at 2 h. \(C_{48h}\) was 0.01 [0.01–0.02] aXa IU at all visits. At baseline and 4 weeks \(AUC_{0-48h}\) was 2.66 [2.19–3.24] and 3.66 [3.00–4.45] aXa IU*h/ml. In 3.0% of dialyses (n = 83/2724) prolonged fistula compression times were documented. Eight patients (7.34%) had at least one episode of minor bleeding. 4) 85.3% of patients had any adverse event, 9.2% were serious without suspected drug relation; and in 32 patients a drug-relation was suspected.
Conclusions
Certoparin appears effective and safe for anticoagulation in patients undergoing maintenance hemodialysis.
Background
Infections with polyomavirus BK virus (BKV) are a common cause of renal dysfunction after renal transplantation and may also be harmful in surgical patients with shock. The aim of the present study was to determine the frequency of BKV viremia in critically ill surgical patients with septic or hemorrhagic shock, and, if viremia is detectable, whether viremia may be associated with renal dysfunction.
Findings
A total of 125 plasma samples from 44 critically ill surgical patients with septic or hemorrhagic shock were tested by real-time polymerase chain reaction (PCR) for BKV DNA during their stay on the intensive care unit (ICU). BKV viremia occurred in four patients, i.e. in three of the septic and in one of the hemorrhagic shock group. There was no association between viremia and renal dysfunction. All positive samples contained a low viral load (< 500 copies/ml).
Conclusions
Since BK viremia was rarely found and with low viral load only in critically ill surgical patients with shock, it is very unlikely that BK viremia results in BK nephropathy later on.
We identified eukaryotic translation elongation factor 1A (eEF1A) Raf-mediated phosphorylation sites and defined their role in the regulation of eEF1A half-life and of apoptosis of human cancer cells. Mass spectrometry identified in vitro S21 and T88 as phosphorylation sites mediated by B-Raf but not C-Raf on eEF1A1 whereas S21 was phosphorylated on eEF1A2 by both B- and C-Raf. Interestingly, S21 belongs to the first eEF1A GTP/GDP-binding consensus sequence. Phosphorylation of S21 was strongly enhanced when both eEF1A isoforms were preincubated prior the assay with C-Raf, suggesting that the eEF1A isoforms can heterodimerize thus increasing the accessibility of S21 to the phosphate. Overexpression of eEF1A1 in COS 7 cells confirmed the phosphorylation of T88 also in vivo. Compared with wt, in COS 7 cells overexpressed phosphodeficient (A) and phospho-mimicking (D) mutants of eEF1A1 (S21A/D and T88A/D) and of eEF1A2 (S21A/D), resulted less stable and more rapidly proteasome degraded. Transfection of S21 A/D eEF1A mutants in H1355 cells increased apoptosis in comparison with the wt isoforms. It indicates that the blockage of S21 interferes with or even supports C-Raf induced apoptosis rather than cell survival. Raf-mediated regulation of this site could be a crucial mechanism involved in the functional switching of eEF1A between its role in protein biosynthesis and its participation in other cellular processes.
Animal models mimicking human diseases have been used extensively to study the pathogenesis of autoimmune diseases and the efficacy of potential therapeutics. They are, however, limited with regard to their similarity to the human disease and cannot be used if the antagonist and its cognate receptor require high similarity in structure or binding. Here, we examine the induction of oxazolone-mediated features of atopic dermatitis (AD) in NOD-scid IL2Rγnull mice engrafted with human peripheral blood mononuclear cells (PBMC). The mice developed the same symptoms as immunocompetent BALB/c mice. Histological alterations induced by oxazolone were characterized by keratosis, epithelial hyperplasia and influx of inflammatory cells into the dermis and epidermis. The cellular infiltrate was identified as human leukocytes, with T cells being the major constituent. In addition, oxazolone increased human serum IgE levels. The response, however, required the engraftment of PBMC derived from patients suffering from AD, which suggests that this model reflects the immunological status of the donor. Taken together, the model described here has the potential to evaluate the efficacy of therapeutics targeting human lymphocytes in vivo and, in addition, might be developed further to elucidate molecular mechanisms inducing and sustaining flares of the disease.
The ITS2 Database
(2012)
The internal transcribed spacer 2 (ITS2) has been used as a phylogenetic marker for more than two decades. As ITS2 research mainly focused on the very variable ITS2 sequence, it confined this marker to low-level phylogenetics only. However, the combination of the ITS2 sequence and its highly conserved secondary structure improves the phylogenetic resolution1 and allows phylogenetic inference at multiple taxonomic ranks, including species delimitation.
The ITS2 Database presents an exhaustive dataset of internal transcribed spacer 2 sequences from NCBI GenBank accurately reannotated. Following an annotation by profile Hidden Markov Models (HMMs), the secondary structure of each sequence is predicted. First, it is tested whether a minimum energy based fold (direct fold) results in a correct, four helix conformation. If this is not the case, the structure is predicted by homology modeling. In homology modeling, an already known secondary structure is transferred to another ITS2 sequence, whose secondary structure was not able to fold correctly in a direct fold.
The ITS2 Database is not only a database for storage and retrieval of ITS2 sequence-structures. It also provides several tools to process your own ITS2 sequences, including annotation, structural prediction, motif detection and BLAST search on the combined sequence-structure information. Moreover, it integrates trimmed versions of 4SALE and ProfDistS for multiple sequence-structure alignment calculation and Neighbor Joining tree reconstruction. Together they form a coherent analysis pipeline from an initial set of sequences to a phylogeny based on sequence and secondary structure.
In a nutshell, this workbench simplifies first phylogenetic analyses to only a few mouse-clicks, while additionally providing tools and data for comprehensive large-scale analyses.
A binary tanglegram is a drawing of a pair of rooted binary trees whose leaf sets are in one-to-one correspondence; matching leaves are connected by inter-tree edges. For applications, for example, in phylogenetics, it is essential that both trees are drawn without edge crossings and that the inter-tree edges have as few crossings as possible. It is known that finding a tanglegram with the minimum number of crossings is NP-hard and that the problem is fixed-parameter tractable with respect to that number.
We prove that under the Unique Games Conjecture there is no constant-factor approximation for binary trees. We show that the problem is NP-hard even if both trees are complete binary trees. For this case we give an O(n 3)-time 2-approximation and a new, simple fixed-parameter algorithm. We show that the maximization version of the dual problem for binary trees can be reduced to a version of MaxCut for which the algorithm of Goemans and Williamson yields a 0.878-approximation.
The adult form of attention deficit/hyperactivity disorder (aADHD) has a prevalence of up to 5% and is the most severe long-term outcome of this common neurodevelopmental disorder. Family studies in clinical samples suggest an increased familial liability for aADHD compared with childhood ADHD (cADHD), whereas twin studies based on self-rated symptoms in adult population samples show moderate heritability estimates of 30–40%. However, using multiple sources of information, the heritability of clinically diagnosed aADHD and cADHD is very similar. Results of candidate gene as well as genome-wide molecular genetic studies in aADHD samples implicate some of the same genes involved in ADHD in children, although in some cases different alleles and different genes may be responsible for adult versus childhood ADHD. Linkage studies have been successful in identifying loci for aADHD and led to the identification of LPHN3 and CDH13 as novel genes associated with ADHD across the lifespan. In addition, studies of rare genetic variants have identified probable causative mutations for aADHD. Use of endophenotypes based on neuropsychology and neuroimaging, as well as next-generation genome analysis and improved statistical and bioinformatic analysis methods hold the promise of identifying additional genetic variants involved in disease etiology. Large, international collaborations have paved the way for well-powered studies. Progress in identifying aADHD risk genes may provide us with tools for the prediction of disease progression in the clinic and better treatment, and ultimately may help to prevent persistence of ADHD into adulthood.
Purpose
Once open abdomen therapy has succeeded, the problem of closing the abdominal wall must be addressed. We present a new four-stage procedure involving the application of a two-component mesh and vacuum conditioning for abdominal wall closure of even large defects. The aim is to prevent the development of a giant ventral hernia and the eventual need for the repair of the abdominal wall.
Methods
Nineteen of 62 patients treated by open abdomen over a two-year period could not receive primary abdominal wall closure. To achieve closure in these patients, we applied the following four-stage procedure: stage 1: abdominal damage control and conditioning of the abdominal wall; stage 2: attachment of a tailored two-component mesh of polyglycolic acid (PGA) and large pore polypropylene (PP) in intraperitoneal position (IPOM) plus placement of a vacuum bandage; stage 3: vacuum therapy for 3–4 weeks to allow granulation of the mesh and optimization of dermatotraction; stage 4: final skin suture. During stage 3, eligible patients were weaned from respirator and mobilized.
Results
The abdominal wall gap in the 19 patients ranged in size from 240 cm2 to more than 900 cm2. An average of 3.44 vacuum dressing changes over 19 days were required to achieve 60–100 % granulation of the surface area, so final skin suture could be made. Already in stage 3, 14 patients (73.68 %) could be weaned from respirator an average of 6.78 days after placement of the two-component mesh; 6 patients (31.57 %) could be mobilized on the edge of the bed and/or to a bedside chair after an average of 13 days. No mesh-related hematomas, seromas, or intestinal fistulas were observed.
Conclusion
The four-stage procedure presented here is a viable option for achieving abdominal wall closure in patients treated with open abdomen, enabling us to avoid the development of planned giant ventral hernias. It has few complications and has the special advantage of allowing mobilization of the patients before final skin closure. Long-term course in a large number of patients must still confirm this result.
Tardigrades have unique stress-adaptations that allow them to survive extremes of cold, heat, radiation and vacuum. To study this, encoded protein clusters and pathways from an ongoing transcriptome study on the tardigrade \(Milnesium\) \(tardigradum\) were analyzed using bioinformatics tools and compared to expressed sequence tags (ESTs) from \(Hypsibius\) \(dujardini\), revealing major pathways involved in resistance against extreme environmental conditions. ESTs are available on the Tardigrade Workbench along with software and databank updates. Our analysis reveals that RNA stability motifs for \(M.\) \(tardigradum\) are different from typical motifs known from higher animals. \(M.\) \(tardigradum\) and \(H.\) \(dujardini\) protein clusters and conserved domains imply metabolic storage pathways for glycogen, glycolipids and specific secondary metabolism as well as stress response pathways (including heat shock proteins, bmh2, and specific repair pathways). Redox-, DNA-, stress- and protein protection pathways complement specific repair capabilities to achieve the strong robustness of \(M.\) \(tardigradum\). These pathways are partly conserved in other animals and their manipulation could boost stress adaptation even in human cells. However, the unique combination of resistance and repair pathways make tardigrades and \(M.\) \(tardigradum\) in particular so highly stress resistant.
The infectious intracellular lifestyle of Salmonella enterica relies on the adaptation to nutritional conditions within the Salmonella-containing vacuole (SCV) in host cells. We summarize latest results on metabolic requirements for Salmonella during infection. This includes intracellular phenotypes of mutant strains based on metabolic modeling and experimental tests, isotopolog profiling using (13)C-compounds in intracellular Salmonella, and complementation of metabolic defects for attenuated mutant strains towards a comprehensive understanding of the metabolic requirements of the intracellular lifestyle of Salmonella. Helpful for this are also genomic comparisons. We outline further recent studies and which analyses of intracellular phenotypes and improved metabolic simulations were done and comment on technical required steps as well as progress involved in the iterative refinement of metabolic flux models, analyses of mutant phenotypes, and isotopolog analyses. Salmonella lifestyle is well-adapted to the SCV and its specific metabolic requirements. Salmonella metabolism adapts rapidly to SCV conditions, the metabolic generalist Salmonella is quite successful in host infection.
As recently reviewed, 1026 neuroprotective drug candidates in stroke research have all failed on their road towards validation and clinical translation, reasons being quality issues in preclinical research and publication bias. Quality control guidelines for preclinical stroke studies have now been established. However, sufficient understanding of the underlying mechanisms of neuronal death after stroke that could be possibly translated into new therapies is lacking. One exception is the hypothesis that cellular death is mediated by oxidative stress. Oxidative stress is defined as an excess of reactive oxygen species (ROS) derived from different possible enzymatic sources. Among these, NADPH oxidases (NOX1-5) stand out as they represent the only known enzyme family that has no other function than to produce ROS. Based on data from different NOX knockout mouse models in ischemic stroke, the most relevant isoform appears to be NOX4. Here we discuss the state-of-the-art of this target with respect to stroke and open questions that need to be addressed on the path towards clinical translation.
Background
A new thromboembolic animal model showed beneficial effects of t-PA with an infarct volume reduction of 36.8% in swiss mice. Because knock-out animal experiments for stroke frequently used C57BL76 mice we evaluated t-PA effects in this mouse strain and measured infarct volume and vascular recanalisation in-vivo by using high-field 9.4 T MRI and a 1H surface cryo coil.
Methods
Clot formation was triggered by microinjection of murine thrombin into the right middle cerebral artery (MCA). Animals (n = 28) were treated with 10 mg/kg, 5 mg/kg or no tissue plasminogen activator (t-PA) 40 min after MCA occlusion. For MR-imaging a Bruker 9.4 T animal system with a 1H surface cryo probe was used and a T2-weighted RARE sequence, a diffusion weighted multishot EPI sequence and a 3D flow-compensated gradient echo TOF angiography were performed.
Results
The infarct volume in animals treated with t-PA was significantly reduced (0.67 ± 1.38 mm3 for 10 mg/kg and 10.9 ± 8.79 mm3 for 5 mg/kg vs. 19.76 ± 2.72 mm3 ; p < 0.001) compared to untreated mice. An additional group was reperfused with t-PA inside the MRI. Already ten minutes after beginning of t-PA treatment, reperfusion flow was re-established in the right MCA. However, signal intensity was lower than in the contralateral MCA. This reduction in cerebral blood flow was attenuated during the first 60 minutes after reperfusion. 24 h after MCA occlusion and reperfusion, no difference in signal intensity of the contralateral and ipsilateral MCAs was observed.
Conclusions
We confirm a t-Pa effect using this stroke model in the C57BL76 mouse strain and demonstrate a chronological sequence MRI imaging after t-PA using a 1H surface cryo coil in a 9.4 T MRI. This setting will allow testing of new thrombolytic strategies for stroke treatment in-vivo in C57BL76 knock-out mice.
Honeybees can easily be trained to perform different types of discrimination tasks under controlled laboratory conditions. This review describes a range of experiments carried out with free-flying forager honeybees under such conditions. The research done over the past 30 or so years suggests that cognitive abilities (learning and perception) in insects are more intricate and flexible than was originally imagined. It has become apparent that honeybees are capable of a variety of visually guided tasks, involving decision making under challenging situations: this includes simultaneously making use of different sensory modalities, such as vision and olfaction, and learning to use abstract concepts such as “sameness” and “difference.” Many studies have shown that decision making in foraging honeybees is highly flexible. The trained animals learn how to solve a task, and do so with a high accuracy, but when they are presented with a new variation of the task, they apply the learnt rules from the earlier setup to the new situation, and solve the new task as well. Honeybees therefore not only feature a rich behavioral repertoire to choose from, but also make decisions most apt to the current situation. The experiments in this review give an insight into the environmental cues and cognitive resources that are probably highly significant for a forager bee that must continually make decisions regarding patches of resources to be exploited.
Proton magnetic resonance imaging (MRI) has recently emerged as a clinical tool to image the lungs. This paper outlines the current technical aspects of MRI pulse sequences, radiofrequency (RF) coils and MRI system requirements needed for imaging the pulmonary parenchyma and vasculature. Lung MRI techniques are presented as a “technical toolkit”, from which MR protocols will be composed in the subsequent papers for comprehensive imaging of lung disease and function (parts 2 and 3). This paper is pitched at MR scientists, technicians and radiologists who are interested in understanding and establishing lung MRI methods. Images from a 1.5 T scanner are used for illustration of the sequences and methods that are highlighted.
Main Messages
• Outline of the hardware and pulse sequence requirements for proton lung MRI
• Overview of pulse sequences for lung parenchyma, vascular and functional imaging with protons
• Demonstration of the pulse-sequence building blocks for clinical lung MRI protocols
Background
Among the modalities for lung imaging, proton magnetic resonance imaging (MRI) has been the latest to be introduced into clinical practice. Its value to replace X-ray and computed tomography (CT) when radiation exposure or iodinated contrast material is contra-indicated is well acknowledged: i.e. for paediatric patients and pregnant women or for scientific use. One of the reasons why MRI of the lung is still rarely used, except in a few centres, is the lack of consistent protocols customised to clinical needs.
Methods
This article makes non-vendor-specific protocol suggestions for general use with state-of-the-art MRI scanners, based on the available literature and a consensus discussion within a panel of experts experienced in lung MRI.
Results
Various sequences have been successfully tested within scientific or clinical environments. MRI of the lung with appropriate combinations of these sequences comprises morphological and functional imaging aspects in a single examination. It serves in difficult clinical problems encountered in daily routine, such as assessment of the mediastinum and chest wall, and even might challenge molecular imaging techniques in the near future.
Conclusion
This article helps new users to implement appropriate protocols on their own MRI platforms.
Main Messages
• MRI of the lung can be readily performed on state-of-the-art 1.5-T MRI scanners.
• Protocol suggestions based on the available literature facilitate its use for routine
• MRI offers solutions for complicated thoracic masses with atelectasis and chest wall invasion.
• MRI is an option for paediatrics and science when CT is contra-indicated
Background
MRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women.
Methods
Provided there is sufficient expertise, magnetic resonance imaging (MRI) may be considered as the preferential modality in specific clinical conditions such as cystic fibrosis and acute pulmonary embolism, since additional functional information on respiratory mechanics and regional lung perfusion is provided. In other cases, such as tumours and pneumonia in children, lung MRI may be considered an alternative or adjunct to other modalities with at least similar diagnostic value.
Results
In interstitial lung disease, the clinical utility of MRI remains to be proven, but it could provide additional information that will be beneficial in research, or at some stage in clinical practice. Customised protocols for chest imaging combine fast breath-hold acquisitions from a “buffet” of sequences. Having introduced details of imaging protocols in previous articles, the aim of this manuscript is to discuss the advantages and limitations of lung MRI in current clinical practice.
Conclusion
New developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed.
Main Messages
• MRI evolves as a third lung imaging modality, combining morphological and functional information.
• It may be considered first choice in cystic fibrosis and pulmonary embolism of young and pregnant patients.
• In other cases (tumours, pneumonia in children), it is an alternative or adjunct to X-ray and CT.
• In interstitial lung disease, it serves for research, but the clinical value remains to be proven.
• New users are advised to make themselves familiar with the particular advantages and limitations.
Rumination has been defined as a mode of responding to distress that involves passively focusing one's attention on symptoms of distress without taking action. This dysfunctional response style intensifies depressed mood, impairs interpersonal problem solving, and leads to more pessimistic future perspectives and less social support. As most of these results were obtained from younger people, it remains unclear how age affects ruminative thinking. Three hundred members of the general public ranging in age from 15 to 87 years were asked about their ruminative styles using the Response Styles Questionnaire (RSQ), depression and satisfaction with life. A Mokken Scale analysis confirmed the two-factor structure of the RSQ with brooding and reflective pondering as subcomponents of rumination. Older participants (63 years and older) reported less ruminative thinking than other age groups. Life satisfaction was associated with brooding and highest for the earlier and latest life stages investigated in this study.
Introduction
Miyoshi myopathy, a type of distal myopathy with predominant involvement of the posterior calf muscles, has been assigned to mutations in the dysferlin gene. However, many of the late-onset limb-girdle and distal myopathies that resemble dysferlinopathy or Miyoshi myopathy remain unclassified, even after extensive immunohistological and genetic analysis.
Case presentation
We report the case of a 59-year-old Caucasian man with distal myopathy and exercise-induced myalgia, preferentially of the leg muscles, closely resembling the Miyoshi phenotype. Magnetic resonance imaging of his calf muscles showed typical fatty replacement of the medial heads of the gastrocnemius muscles and soleus muscles, with progression to the adductor longus muscles over a time course of two years. However, genetic analysis revealed that the phenotype of our patient was not related to a mutation in the dysferlin gene but to a novel homozygous splice mutation in the anoctamin 5 gene. Mutations in the anoctamin 5 gene have so far been identified only in some cases of limb-girdle and distal myopathy. Mutations in the anoctamin 5 gene have been assigned to limb-girdle muscular dystrophy type 2L, while distal Miyoshi-like phenotypes have been classified as Miyoshi myopathy type 3.
Conclusion
The case presented in this report further strengthens the underlying genetic heterogeneity in Miyoshi myopathy-like phenotypes and adds another family to non-dysferlin, Miyoshi myopathy type 3 of late-onset. Furthermore, our case supports the recent observation that anoctamin 5 mutations are a primary cause of distal non-dysferlin myopathies. Therefore, given the increasing number of anoctamin 5 mutations in Miyoshi-like phenotypes, genetic analysis should include an anoctamin 5 screen in late-onset limb-girdle and distal myopathies.